TW202007711A - Curable compositions, cured film, and color filter substrate - Google Patents

Curable compositions, cured film, and color filter substrate Download PDF

Info

Publication number
TW202007711A
TW202007711A TW108122409A TW108122409A TW202007711A TW 202007711 A TW202007711 A TW 202007711A TW 108122409 A TW108122409 A TW 108122409A TW 108122409 A TW108122409 A TW 108122409A TW 202007711 A TW202007711 A TW 202007711A
Authority
TW
Taiwan
Prior art keywords
compound
curable composition
polyfunctional
weight
carboxyl
Prior art date
Application number
TW108122409A
Other languages
Chinese (zh)
Other versions
TWI814847B (en
Inventor
堀田佑策
木村佑希
窪内希恵
Original Assignee
日商捷恩智股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商捷恩智股份有限公司 filed Critical 日商捷恩智股份有限公司
Publication of TW202007711A publication Critical patent/TW202007711A/en
Application granted granted Critical
Publication of TWI814847B publication Critical patent/TWI814847B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/16Polyester-imides
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D179/00Coating compositions based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen, with or without oxygen, or carbon only, not provided for in groups C09D161/00 - C09D177/00
    • C09D179/04Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
    • C09D179/08Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G59/00Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
    • C08G59/18Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
    • C08G59/40Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the curing agents used
    • C08G59/4007Curing agents not provided for by the groups C08G59/42 - C08G59/66
    • C08G59/4014Nitrogen containing compounds
    • C08G59/4042Imines; Imides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1057Polyimides containing other atoms than carbon, hydrogen, nitrogen or oxygen in the main chain
    • C08G73/106Polyimides containing other atoms than carbon, hydrogen, nitrogen or oxygen in the main chain containing silicon
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/12Unsaturated polyimide precursors
    • C08G73/121Preparatory processes from unsaturated precursors and polyamines
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D7/00Features of coating compositions, not provided for in group C09D5/00; Processes for incorporating ingredients in coating compositions
    • C09D7/40Additives
    • C09D7/60Additives non-macromolecular
    • C09D7/63Additives non-macromolecular organic
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D7/00Features of coating compositions, not provided for in group C09D5/00; Processes for incorporating ingredients in coating compositions
    • C09D7/40Additives
    • C09D7/65Additives macromolecular
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B1/00Optical elements characterised by the material of which they are made; Optical coatings for optical elements
    • G02B1/10Optical coatings produced by application to, or surface treatment of, optical elements
    • G02B1/14Protective coatings, e.g. hard coatings
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B5/00Optical elements other than lenses
    • G02B5/20Filters
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1335Structural association of cells with optical devices, e.g. polarisers or reflectors
    • G02F1/133509Filters, e.g. light shielding masks
    • G02F1/133514Colour filters
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1335Structural association of cells with optical devices, e.g. polarisers or reflectors
    • G02F1/133509Filters, e.g. light shielding masks
    • G02F1/133514Colour filters
    • G02F1/133519Overcoatings
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials
    • G03F7/038Macromolecular compounds which are rendered insoluble or differentially wettable
    • G03F7/0387Polyamides or polyimides
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials
    • G03F7/09Photosensitive materials characterised by structural details, e.g. supports, auxiliary layers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2205/00Polymer mixtures characterised by other features
    • C08L2205/02Polymer mixtures characterised by other features containing two or more polymers of the same C08L -group
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2205/00Polymer mixtures characterised by other features
    • C08L2205/03Polymer mixtures characterised by other features containing three or more polymers in a blend

Landscapes

  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nonlinear Science (AREA)
  • Optics & Photonics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mathematical Physics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Structural Engineering (AREA)
  • Architecture (AREA)
  • Optical Filters (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Epoxy Resins (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

The present invention relates to a curable composition, a cured film and a color filter substrate. The curable composition comprises an imide compound (A), a polyfunctional carboxyl compound (B), and a polyfunctional epoxy compound (C), wherein the imide compound (A) is a reaction product using an anhydride (a1) having a polymerizable double bond and an alkoxysilyl compound (a2) having an amino group as essential raw materials, the polyfunctional carboxyl compound (B) is a compound having three or more carboxyl groups per molecule, and the polyfunctional epoxy compound (C) is a compound having three or more epoxy groups per molecule. The curable composition of the present invention has low viscosity and high planarity. By using the curable composition of the present invention, a cured film having high transparency, heat resistance and photo-alignment can be obtained.

Description

硬化性組成物、硬化膜及彩色濾光片基板Curable composition, cured film, and color filter substrate

本發明是有關於一種提供具有光配向性的彩色濾光片保護膜的硬化性組成物、由所述硬化性組成物形成的硬化膜及包括所述硬化膜的彩色濾光片基板。The present invention relates to a curable composition that provides a color filter protective film having optical alignment, a cured film formed from the curable composition, and a color filter substrate including the cured film.

在彩色顯示用的顯示元件等中包括彩色濾光片基板。彩色濾光片基板包括紅(R)、綠(G)及藍(B)的著色體或防止混色用的黑色矩陣,且在彩色濾光片基板表面存在階差。為了使液晶顯示元件的單元間隙在面內均勻化,或使形成於彩色濾光片基板上的光學功能膜的膜厚均勻化,而使用具有使彩色濾光片基板表面的階差平坦化的功能的彩色濾光片保護膜。另外,為了對液晶顯示元件中的液晶分子的配向方向進行控制,或在使用聚合性液晶組成物來形成光學功能膜時,對聚合性液晶分子的配向方向進行控制,而包括具有對液晶分子的配向方向進行控制的功能的配向膜。為了實現液晶顯示元件的薄型化或輕量化,而開發有兼具所述兩種膜分別進行的兩種功能且具有配向性的彩色濾光片保護膜。A color filter substrate is included in a display element for color display or the like. The color filter substrate includes red (R), green (G), and blue (B) color bodies or a black matrix for preventing color mixing, and there is a step difference on the surface of the color filter substrate. In order to make the cell gap of the liquid crystal display element uniform within the plane, or to make the thickness of the optical functional film formed on the color filter substrate uniform, a method of flattening the step of the surface of the color filter substrate is used. Functional color filter protection film. In addition, in order to control the alignment direction of the liquid crystal molecules in the liquid crystal display element, or when the polymerizable liquid crystal composition is used to form the optical functional film, the alignment direction of the polymerizable liquid crystal molecules is controlled. Alignment film with the function of controlling the alignment direction. In order to achieve a thinner or lighter liquid crystal display element, a color filter protective film that has both the two functions performed by the two films and has an alignment property has been developed.

具有配向性的彩色濾光片保護膜的例子為專利文獻1中記載的具有摩擦配向性的彩色濾光片保護膜及專利文獻2中記載的具有光配向性的彩色濾光片保護膜。提供前一保護膜的組成物為包含聚醯亞胺及環氧化合物的硬化性組成物,前一保護膜的配向處理方法為摩擦法。提供後一保護膜的組成物為包含具有肉桂醯基等光配向性基及環氧基等交聯性基的聚合體以及聚酯醯胺酸即交聯成分的硬化性組成物,後者的配向處理是利用直線偏光紫外線照射來進行。迄今為止,為了提高液晶顯示元件的顯示品質,推進配向處理步驟自因直接接觸膜而成為產生靜電的原因的摩擦法置換成非接觸的直線偏光紫外線照射,並謀求具有光配向性的彩色濾光片保護膜及提供所述彩色濾光片保護膜的組成物。Examples of the color filter protective film with alignment are the color filter protective film with friction alignment described in Patent Document 1 and the color filter protective film with optical alignment described in Patent Document 2. The composition providing the former protective film is a hardening composition containing polyimide and an epoxy compound, and the alignment treatment method of the former protective film is the friction method. The composition for providing the latter protective film is a hardening composition containing a polymer having a photo-alignment group such as a cinnamyl group and a cross-linking group such as an epoxy group and a cross-linking component such as polyester amide acid, and the alignment of the latter The treatment is performed using linearly polarized ultraviolet irradiation. Up to now, in order to improve the display quality of liquid crystal display elements, the alignment process has been promoted to replace the friction method, which causes static electricity due to direct contact with the film, with non-contact linearly polarized ultraviolet irradiation, and to seek color filters with optical alignment A film protection film and a composition for providing the color filter protection film.

但是,為了應對近年來的對於顯示元件的低消耗電力化及長壽命化的需求,對專利文獻2中記載的具有光配向性的彩色濾光片保護膜要求提高兩種特性。第一種是以提高液晶顯示元件的透光性為目的的保護膜的透明性的提高。第二種是以減少由來自保護膜的脫氣引起的對液晶顯示元件的其他構件的影響為目的的保護膜的耐熱性的提高(追加加熱時的熱重量減少量的減低)。However, in order to cope with the recent demands for lower power consumption and longer life of display elements, the color filter protective film with optical alignment described in Patent Document 2 is required to improve both characteristics. The first is to improve the transparency of the protective film for the purpose of improving the light transmittance of the liquid crystal display element. The second type is the improvement of the heat resistance of the protective film (the reduction in the amount of thermal weight loss during additional heating) for the purpose of reducing the influence on the other members of the liquid crystal display element caused by the degassing from the protective film.

另外,作為具有光配向性的彩色濾光片保護膜的形成中所使用的組成物,考慮使用光配向膜用組成物(例如,專利文獻3)。但是,專利文獻3中記載的光配向膜用組成物的黏性高(塗布所述組成物並將組成物用溶劑去除而獲得的塗膜容易發黏)。因此,存在如下問題:在形成具有光配向性的彩色濾光片保護膜時,異物附著;或作業者的手指接觸塗膜表面而附有痕跡。進而,存在如下問題:將所述光配向膜用組成物以用作通常的光配向膜的膜厚(例如,100 nm)形成時的平坦化性不良,即便在以用作通常的彩色濾光片保護膜的膜厚(例如,1.5 μm)形成的情況下,平坦化性也不良,且液晶顯示元件的顯示品質低。In addition, as a composition used in the formation of a color filter protective film having optical alignment, it is considered to use a composition for an optical alignment film (for example, Patent Document 3). However, the composition for a photo-alignment film described in Patent Document 3 has high viscosity (the coating film obtained by coating the composition and removing the composition with a solvent is easily sticky). Therefore, there is a problem in that, when forming a color filter protective film having photo-alignment, a foreign substance adheres; or an operator's finger touches the surface of the coating film to cause a trace. Furthermore, there is a problem in that the composition for a photo-alignment film is formed into a film thickness (for example, 100 nm) that is used as a general photo-alignment film, and the flatness is poor even when it is used as a general color filter. When the film thickness of the sheet protective film (for example, 1.5 μm) is formed, the flatness is also poor, and the display quality of the liquid crystal display element is low.

根據以上所述,期待開發一種提供透明性、耐熱性及光配向性高的硬化膜的、黏性低且平坦化性高的硬化性組成物。 [現有技術文獻] [專利文獻]Based on the above, it is expected to develop a curable composition that provides a cured film with high transparency, heat resistance, and high optical alignment, has low viscosity, and has high planarity. [Prior Art Literature] [Patent Literature]

[專利文獻1]日本專利特開平9-230364 [專利文獻2]日本專利特開2014-84355 [專利文獻3]日本專利特開2015-49419[Patent Document 1] Japanese Patent Laid-Open No. 9-230364 [Patent Document 2] Japanese Patent Laid-Open No. 2014-84355 [Patent Document 3] Japanese Patent Laid-Open No. 2015-49419

[發明所要解決的問題] 本發明提供一種提供透明性、耐熱性及光配向性高的硬化膜的、黏性低且平坦化性高的硬化性組成物、由所述硬化性組成物獲得的硬化膜及包括所述硬化膜的彩色濾光片基板。 [解決問題的技術手段][Problems to be solved by the invention] The present invention provides a curable composition that provides a cured film with high transparency, heat resistance, and high optical alignment, low viscosity, and high planarity, a cured film obtained from the curable composition, and including the cured film Film of color filter substrate. [Technical means to solve the problem]

本發明者等人為了解決所述問題而進行了努力研究,結果發現通過如下硬化性組成物及將所述硬化性組成物硬化而獲得的硬化膜而可達成所述目的,從而完成了本發明,所述硬化性組成物包含醯亞胺化合物(A)、多官能羧基化合物(B)及多官能環氧化合物(C),且所述硬化性組成物中,醯亞胺化合物(A)為將具有聚合性雙鍵的酸酐(a1)及具有氨基的烷氧基矽烷基化合物(a2)設為必需原料的反應產物,多官能羧基化合物(B)為每一分子具有三個以上的羧基的化合物,所述多官能環氧化合物(C)為每一分子具有三個以上的環氧基的化合物。The inventors of the present invention conducted intensive studies to solve the above problems, and as a result, they found that the above objects can be achieved by the following curable composition and a cured film obtained by curing the curable composition, and completed the present invention. , The curable composition includes an amide imine compound (A), a multifunctional carboxyl compound (B), and a multifunctional epoxy compound (C), and in the curable composition, the amide imine compound (A) is The reaction product using an acid anhydride (a1) having a polymerizable double bond and an alkoxysilane group compound (a2) having an amino group as essential raw materials, and a polyfunctional carboxyl compound (B) having three or more carboxyl groups per molecule Compound, the multifunctional epoxy compound (C) is a compound having three or more epoxy groups per molecule.

[1] 一種硬化性組成物,其包含醯亞胺化合物(A)、多官能羧基化合物(B)及多官能環氧化合物(C),且所述硬化性組成物中, 所述醯亞胺化合物(A)為來自將具有聚合性雙鍵的酸酐(a1)及具有氨基的烷氧基矽烷基化合物(a2)設為必需的原料的反應產物, 所述多官能羧基化合物(B)為每一分子具有三個以上的羧基的化合物, 所述多官能環氧化合物(C)為每一分子具有三個以上的環氧基的化合物。[1] A curable composition comprising an amide imine compound (A), a polyfunctional carboxyl compound (B) and a polyfunctional epoxy compound (C), and in the curable composition, The amide imine compound (A) is a reaction product derived from an acid anhydride (a1) having a polymerizable double bond and an alkoxysilane group compound (a2) having an amino group as necessary raw materials, The multifunctional carboxyl compound (B) is a compound having three or more carboxyl groups per molecule, The multifunctional epoxy compound (C) is a compound having three or more epoxy groups per molecule.

[2] 根據[1]項所述的硬化性組成物,其中在所述醯亞胺化合物(A)、所述多官能羧基化合物(B)及所述多官能環氧化合物(C)的總量100重量%中,所述醯亞胺化合物(A)為5重量%~80重量%; 在所述多官能羧基化合物(B)及所述多官能環氧化合物(C)的總量100重量%中,所述多官能羧基化合物(B)為20重量%~80重量%。[2] The curable composition according to [1], wherein the total of the amide imine compound (A), the polyfunctional carboxyl compound (B), and the polyfunctional epoxy compound (C) In an amount of 100% by weight, the amide imine compound (A) is 5% to 80% by weight; In the total amount of 100% by weight of the polyfunctional carboxyl compound (B) and the polyfunctional epoxy compound (C), the polyfunctional carboxyl compound (B) is 20% to 80% by weight.

[3] 根據[1]項所述的硬化性組成物,其中在所述醯亞胺化合物(A)、所述多官能羧基化合物(B)及所述多官能環氧化合物(C)的總量100重量%中,所述醯亞胺化合物(A)為15重量%~60重量%; 在所述多官能羧基化合物(B)及所述多官能環氧化合物(C)的總量100重量%中,所述多官能羧基化合物(B)為40重量%~75重量%。[3] The curable composition according to item [1], wherein the total of the amide imine compound (A), the polyfunctional carboxyl compound (B), and the polyfunctional epoxy compound (C) In an amount of 100% by weight, the amide imine compound (A) is 15% to 60% by weight; In the total amount of 100% by weight of the polyfunctional carboxyl compound (B) and the polyfunctional epoxy compound (C), the polyfunctional carboxyl compound (B) is 40% to 75% by weight.

[4] 根據[1]至[3]中任一項所述的硬化性組成物,其中所述具有聚合性雙鍵的酸酐(a1)為選自下述式(1)所表示的化合物及下述式(2)所表示的化合物中的至少一種。

Figure 02_image001
式(1)中,R1 及R2 分別獨立地為氫或碳數1~5的烷基。
Figure 02_image003
式(2)中,R3 為氫或碳數1~5的烷基。[4] The curable composition according to any one of [1] to [3], wherein the acid anhydride (a1) having a polymerizable double bond is selected from a compound represented by the following formula (1) and At least one of the compounds represented by the following formula (2).
Figure 02_image001
In formula (1), R 1 and R 2 are each independently hydrogen or a C 1-5 alkyl group.
Figure 02_image003
In formula (2), R 3 is hydrogen or a C 1-5 alkyl group.

[5] 根據[1]至[4]中任一項所述的硬化性組成物,其中所述具有聚合性雙鍵的酸酐(a1)為選自馬來酸酐、檸康酸酐及衣康酸酐中的至少一種。[5] The curable composition according to any one of [1] to [4], wherein the acid anhydride (a1) having a polymerizable double bond is selected from maleic anhydride, citraconic anhydride and itaconic anhydride At least one of them.

[6] 根據[1]至[5]中任一項所述的硬化性組成物,其中所述具有氨基的烷氧基矽烷基化合物(a2)為選自3-氨基丙基三甲氧基矽烷、3-氨基丙基三乙氧基矽烷、4-氨基苯基三甲氧基矽烷及4-氨基苯基三乙氧基矽烷中的至少一種。[6] The hardenable composition according to any one of [1] to [5], wherein the alkoxysilane group compound (a2) having an amino group is selected from 3-aminopropyltrimethoxysilane , At least one of 3-aminopropyltriethoxysilane, 4-aminophenyltrimethoxysilane and 4-aminophenyltriethoxysilane.

[7] 根據[1]至[6]中任一項所述的硬化性組成物,其中所述多官能羧基化合物(B)為將四羧酸二酐、二胺及多元羥基化合物設為必需原料的聚酯醯胺酸。[7] The curable composition according to any one of [1] to [6], wherein the polyfunctional carboxyl compound (B) is a tetracarboxylic dianhydride, a diamine, and a polyhydric hydroxyl compound. The raw material of polyester amide acid.

[8] 一種硬化膜,其是使根據[1]至[7]中任一項所述的硬化性組成物硬化而獲得。[8] A cured film obtained by curing the curable composition according to any one of [1] to [7].

[9] 一種彩色濾光片基板,其包括根據[8]項所述的硬化膜。 [發明的效果][9] A color filter substrate including the cured film according to item [8]. [Effect of invention]

本發明的優選的實施方式的硬化性組成物為提供透明性、耐熱性及光配向性高的硬化膜的、黏性低且平坦化性高的硬化性組成物。由所述硬化性組成物獲得的硬化膜可用作彩色濾光片保護膜。由於所述硬化膜的透明性高、所述硬化性組成物的平坦化性高及所述硬化性組成物的黏性低,因此在形成硬化膜時,異物的附著得到減低,因此在將所述硬化膜用作彩色濾光片保護膜的情況下,液晶顯示元件的顯示品質高。由於所述硬化膜的耐熱性高,因此包括所述硬化膜的顯示元件中,由來自所述硬化膜的脫氣引起的對其他構件的影響小。另外,由於所述硬化膜的光配向性高,因此可不使用配向膜而進行液晶分子的配向控制。The curable composition of a preferred embodiment of the present invention is a curable composition that provides a cured film with high transparency, heat resistance, and high optical alignment, and has low viscosity and high planarization. The cured film obtained from the curable composition can be used as a color filter protective film. Since the cured film has high transparency, the curable composition has high flatness and the viscosity of the curable composition is low, when forming a cured film, adhesion of foreign matter is reduced, so when When the cured film is used as a color filter protective film, the display quality of the liquid crystal display element is high. Since the cured film has high heat resistance, the display element including the cured film has little influence on other members caused by outgassing from the cured film. In addition, since the cured film has high optical alignment, alignment control of liquid crystal molecules can be performed without using an alignment film.

本說明書中,為了表示「丙烯酸」及「甲基丙烯酸」的一者或兩者,有時表述為「(甲基)丙烯酸」。同樣地,為了表示「丙烯酸酯」及「甲基丙烯酸酯」的一者或兩者,有時表述為「(甲基)丙烯酸酯」,為了表示「丙烯醯氧基」及「甲基丙烯醯氧基」的一者或兩者,有時表述為「(甲基)丙烯醯氧基」。In this specification, in order to show one or both of "acrylic acid" and "methacrylic acid", it is sometimes expressed as "(meth)acrylic acid". Similarly, in order to indicate one or both of "acrylate" and "methacrylate", it is sometimes expressed as "(meth)acrylate", in order to indicate "acryloyloxy" and "methacryloyl" One or both of "oxy" is sometimes expressed as "(meth)acryloyloxy".

<1.本發明的硬化性組成物> 本發明的硬化性組成物的特徵在於:包含醯亞胺化合物(A)、多官能羧基化合物(B)及多官能環氧化合物(C)。<1. The curable composition of the present invention> The curable composition of the present invention is characterized by containing an amide imine compound (A), a polyfunctional carboxyl compound (B), and a polyfunctional epoxy compound (C).

在本發明的硬化性組成物中,存在醯亞胺化合物(A)、多官能羧基化合物(B)及多官能環氧化合物(C)的優選的調配率。為了獲得光配向性高的硬化膜,醯亞胺化合物(A)、多官能羧基化合物(B)及多官能環氧化合物(C)的總量100重量%中的醯亞胺化合物(A)的調配率優選為5重量%以上,更優選為15重量%以上。為了獲得黏性低且平坦化性高的硬化性組成物,醯亞胺化合物(A)、多官能羧基化合物(B)及多官能環氧化合物(C)的總量100重量%中的醯亞胺化合物(A)的調配率優選為80重量%以下,更優選為60重量%以下。為了獲得耐熱性高且光配向性高的硬化膜,多官能羧基化合物(B)及多官能環氧化合物(C)的總量100重量%中的多官能羧基化合物(B)的調配率優選為20重量%~80重量%,更優選40重量%~75重量%。In the curable composition of the present invention, there are preferable compounding ratios of the amide imine compound (A), the polyfunctional carboxyl compound (B), and the polyfunctional epoxy compound (C). In order to obtain a hardened film with high optical alignment, the imidate compound (A), the amide imide compound (A), the polyfunctional carboxyl compound (B) and the polyfunctional epoxy compound (C) are 100% by weight of the amide imine compound (A). The compounding ratio is preferably 5% by weight or more, and more preferably 15% by weight or more. In order to obtain a hardenable composition with low viscosity and high flatness, the acetylene compound (A), the polyfunctional carboxyl compound (B), and the polyfunctional epoxy compound (C) are contained in 100% by weight The compounding ratio of the amine compound (A) is preferably 80% by weight or less, and more preferably 60% by weight or less. In order to obtain a cured film with high heat resistance and high optical alignment, the compounding rate of the polyfunctional carboxyl compound (B) in 100% by weight of the total amount of the polyfunctional carboxyl compound (B) and the polyfunctional epoxy compound (C) is preferably: 20% by weight to 80% by weight, more preferably 40% by weight to 75% by weight.

本說明書中,有時將醯亞胺化合物(A)、多官能羧基化合物(B)及多官能環氧化合物(C)總稱而表述為「主要成分」,有時將醯亞胺化合物(A)、多官能羧基化合物(B)及多官能環氧化合物(C)的總量表述為「主要成分量」。In this specification, the amide imine compound (A), the polyfunctional carboxyl compound (B) and the polyfunctional epoxy compound (C) are sometimes collectively expressed as "main components", and the amide imine compound (A) is sometimes referred to as The total amount of polyfunctional carboxyl compound (B) and polyfunctional epoxy compound (C) is expressed as "main component amount".

<1-1.醯亞胺化合物(A)> 本發明中所使用的醯亞胺化合物(A)為來自將具有聚合性雙鍵的酸酐(a1)及具有氨基的烷氧基矽烷基化合物(a2)設為必需的原料的反應產物。<1-1. Acetylene imine compound (A)> The amide imine compound (A) used in the present invention is a reaction product derived from an acid anhydride (a1) having a polymerizable double bond and an alkoxysilane group compound (a2) having an amino group as necessary raw materials.

關於醯亞胺化合物(A)的原料,具有聚合性雙鍵的酸酐(a1)及具有氨基的烷氧基矽烷基化合物(a2)的優選的含有比以具有聚合性雙鍵的酸酐(a1)的酸酐基及具有氨基的烷氧基矽烷基化合物(a2)的氨基的莫耳比(酸酐基/氨基)計為0.8以上且1.2以下,更優選的含有比為0.9以上且1.1以下。若為所述含有比,則對於具有光配向性而言所需的曝光量小。Regarding the raw material of the amide imine compound (A), the preferable content ratio of the acid anhydride (a1) having a polymerizable double bond and the alkoxysilane group compound (a2) having an amino group is the acid anhydride (a1) having a polymerizable double bond The molar ratio (anhydride group/amino group) of the amino group of the acid anhydride group and the alkoxysilane group compound (a2) having an amino group is 0.8 or more and 1.2 or less, and the more preferable content ratio is 0.9 or more and 1.1 or less. If it is the content ratio, the exposure amount required to have photoalignment is small.

<1-1-1.具有聚合性雙鍵的酸酐(a1)> 本發明中,作為用以獲得醯亞胺化合物(A)的原料,使用具有聚合性雙鍵的酸酐(a1)。<1-1-1. Anhydride with polymerizable double bond (a1)> In the present invention, as a raw material for obtaining the amide imine compound (A), an acid anhydride (a1) having a polymerizable double bond is used.

若考慮原料的獲取容易性及所獲得的醯亞胺化合物(A)對溶劑的溶解性,則優選的具有聚合性雙鍵的酸酐(a1)為下述式(1)所表示的化合物及下述式(2)所表示的化合物。In consideration of the ease of obtaining raw materials and the solubility of the obtained imide compound (A) in a solvent, the preferred acid anhydride (a1) having a polymerizable double bond is a compound represented by the following formula (1) and the following The compound represented by the formula (2).

Figure 02_image001
式(1)中,R1 及R2 分別獨立地為氫或碳數1~5的烷基。
Figure 02_image001
In formula (1), R 1 and R 2 are each independently hydrogen or a C 1-5 alkyl group.

Figure 02_image003
式(2)中,R3 為氫或碳數1~5的烷基。
Figure 02_image003
In formula (2), R 3 is hydrogen or a C 1-5 alkyl group.

所述式(1)中,R1 及R2 分別獨立地優選為氫或甲基;更優選為R1 及R2 均為氫(式(1)所表示的化合物為馬來酸酐)及R1 及R2 的一者為氫且另一者為甲基(式(1)所表示的化合物為檸康酸酐)。In the formula (1), R 1 and R 2 are each independently preferably hydrogen or methyl; more preferably, both R 1 and R 2 are hydrogen (the compound represented by formula (1) is maleic anhydride) and R One of 1 and R 2 is hydrogen and the other is methyl (the compound represented by formula (1) is citraconic anhydride).

所述式(2)中,R3 優選為氫或甲基;更優選為R3 為氫(式(2)所表示的化合物為衣康酸酐)。In the formula (2), R 3 is preferably hydrogen or methyl; more preferably, R 3 is hydrogen (the compound represented by formula (2) is itaconic anhydride).

具有聚合性雙鍵的酸酐(a1)特別優選為檸康酸酐。關於檸康酸酐,在製造醯亞胺化合物(A)時,聚合性雙鍵的反應性低而容易製造醯亞胺化合物(A)。The acid anhydride (a1) having a polymerizable double bond is particularly preferably citraconic anhydride. Regarding citraconic anhydride, when producing the imidate compound (A), the reactivity of the polymerizable double bond is low and the imidate compound (A) is easily produced.

<1-1-2.具有氨基的烷氧基矽烷基化合物(a2)> 本發明中,作為用以獲得醯亞胺化合物(A)的原料,使用具有氨基的烷氧基矽烷基化合物(a2)。<1-1-2. Alkoxysilane group compound having an amino group (a2)> In the present invention, as a raw material for obtaining the amide imine compound (A), an alkoxysilane group compound (a2) having an amino group is used.

具有氨基的烷氧基矽烷基化合物(a2)的具體例為3-氨基丙基三甲氧基矽烷、3-氨基丙基三乙氧基矽烷、3-氨基丙基甲基二甲氧基矽烷、3-氨基丙基甲基二乙氧基矽烷、4-氨基苯基三甲氧基矽烷、4-氨基苯基三乙氧基矽烷、3-(2-氨基乙基氨基)丙基三甲氧基矽烷及3-(2-氨基乙基氨基)丙基三乙氧基矽烷。可使用這些化合物中的一種以上。Specific examples of the alkoxysilane group compound (a2) having an amino group are 3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, 3-aminopropylmethyldimethoxysilane, 3-aminopropylmethyl diethoxysilane, 4-aminophenyltrimethoxysilane, 4-aminophenyltriethoxysilane, 3-(2-aminoethylamino)propyltrimethoxysilane And 3-(2-aminoethylamino)propyltriethoxysilane. One or more of these compounds can be used.

若考慮反應性及原料的獲取容易性,則優選為3-氨基丙基三甲氧基矽烷、3-氨基丙基三乙氧基矽烷、3-氨基丙基甲基二甲氧基矽烷及3-氨基丙基甲基二乙氧基矽烷,更優選為3-氨基丙基三甲氧基矽烷及3-氨基丙基三乙氧基矽烷。In consideration of reactivity and ease of obtaining raw materials, 3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, 3-aminopropylmethyldimethoxysilane, and 3- The aminopropylmethyl diethoxysilane is more preferably 3-aminopropyltrimethoxysilane and 3-aminopropyltriethoxysilane.

<1-1-3.醯亞胺化合物(A)的合成方法> 醯亞胺化合物(A)的反應方法並無特別限定,但優選為在使用溶劑的溶液中的反應。本說明書中,將用以獲得醯亞胺化合物(A)的合成中所使用的溶劑簡單表述為「合成溶劑」。具有聚合性雙鍵的酸酐(a1)及具有氨基的烷氧基矽烷基化合物(a2)通過在溶液中且在室溫下進行攪拌而容易進行反應並生成醯胺酸。通過生成醯胺酸時的反應熱而系統內的溫度上升,因此通過在溶液中進行而容易控制系統內的溫度。<1-1-3. Synthesis method of amide imine compound (A)> The reaction method of the amide imine compound (A) is not particularly limited, but it is preferably a reaction in a solution using a solvent. In this specification, the solvent used in the synthesis to obtain the amide imine compound (A) is simply expressed as "synthetic solvent". The acid anhydride (a1) having a polymerizable double bond and the alkoxysilane group compound (a2) having an amino group are easily reacted by being stirred in a solution at room temperature and generate an amidic acid. The temperature of the system rises due to the heat of reaction when the amide acid is produced, so it is easy to control the temperature in the system by proceeding in the solution.

其後,對醯胺酸進行加熱並加以醯亞胺化,從而獲得醯亞胺化合物(A)。所獲得的醯亞胺化合物(A)具有含有聚合性雙鍵及醯亞胺結構的基,且具有未反應的烷氧基矽烷基。Thereafter, the amide acid is heated and imidate, thereby obtaining the imidate compound (A). The obtained imide compound (A) has a group containing a polymerizable double bond and an imide structure, and has an unreacted alkoxysilyl group.

進行醯亞胺化時的加熱溫度為60℃~150℃,優選為80℃~130℃。也可添加鹼催化劑作為醯亞胺化催化劑。鹼催化劑的例子為吡啶、三乙胺、三甲胺、三丁胺及三辛胺。另外,出於抑制所述反應中所引發的光聚合性基的聚合的目的,也可並用聚合抑制劑。聚合抑制劑的例子為2,2,6,6-四甲基呱啶基-1-氧基、4-羥基-2,2,6,6-四甲基呱啶基-1-氧基、三苯基四聯氮基(verdazyl)、對甲氧基苯酚、氫醌及二丁基羥基甲苯。The heating temperature at the time of imidization is 60°C to 150°C, preferably 80°C to 130°C. Alkali catalysts can also be added as amide imidization catalysts. Examples of basic catalysts are pyridine, triethylamine, trimethylamine, tributylamine and trioctylamine. In addition, for the purpose of suppressing the polymerization of the photopolymerizable group initiated in the reaction, a polymerization inhibitor may be used in combination. Examples of polymerization inhibitors are 2,2,6,6-tetramethylpyridin-1-oxy, 4-hydroxy-2,2,6,6-tetramethylpyridin-1-oxy, Triphenyltetrazyl (verdazyl), p-methoxyphenol, hydroquinone and dibutylhydroxytoluene.

合成溶劑若為可溶解作為原料的具有聚合性雙鍵的酸酐(a1)、具有氨基的烷氧基矽烷基化合物(a2)及醯亞胺化合物(A)者,則並無特別限定。通過選擇具有羥基的溶劑作為合成溶劑,在合成醯亞胺化合物(A)時,可使烷氧基矽烷基部位的水解縮合的反應速度降低。The synthesis solvent is not particularly limited as long as it can dissolve the acid anhydride (a1) having a polymerizable double bond as a raw material, the alkoxysilane group compound (a2) having an amino group, and the amide imine compound (A). By selecting a solvent having a hydroxyl group as the synthesis solvent, the synthesis reaction of the amide imine compound (A) can reduce the reaction rate of the hydrolysis condensation of the alkoxysilane group.

除選擇具有羥基的溶劑作為合成溶劑以外,也對合成時的原料的濃度或加熱溫度進行調整,由此在合成醯亞胺化合物(A)時,可對烷氧基矽烷基部位的水解縮合的反應速度進行控制。In addition to selecting a solvent having a hydroxyl group as the synthesis solvent, the concentration of the raw material during the synthesis or the heating temperature is also adjusted, so that when the amide imine compound (A) is synthesized, the alkoxysilane group can be hydrolyzed and condensed. The reaction rate is controlled.

在進行合成時,若以高濃度使用原料並在高溫下進行加熱,則最初的反應中所生成的醯胺酸自身發揮酸催化劑的作用,並且通過因醯胺酸的醯亞胺化而生成的水來引發烷氧基矽烷基的水解反應,因此可提高分子量。所述反應時的加熱溫度優選為100℃~150℃。另外,添加水及甲酸等酸催化劑,進而進行加熱,並將低沸點成分蒸餾去除,由此可進一步提高分子量。In the synthesis, if the raw materials are used in a high concentration and heated at a high temperature, the amide acid generated in the initial reaction itself functions as an acid catalyst and is generated by the imidate of the amide acid Water initiates the hydrolysis reaction of the alkoxysilane group, so the molecular weight can be increased. The heating temperature during the reaction is preferably 100°C to 150°C. In addition, an acid catalyst such as water and formic acid is added, and further heating is performed to distill off the low boiling point component, thereby further increasing the molecular weight.

<1-1-4.合成溶劑的具體例> 合成溶劑的具體例為乙二醇、丙二醇、丁二醇、二乙二醇、二丙二醇及三乙二醇等二醇化合物; 乙二醇單甲醚、乙二醇單乙醚、乙二醇單丁醚、丙二醇單甲醚(以下簡記為「PGME」)、丙二醇單乙醚、丙二醇單丁醚(以下簡記為「PGBE」)、丁二醇單甲醚、二乙二醇單甲醚、二乙二醇單乙醚、二乙二醇單丁醚、二丙二醇單甲醚、三乙二醇單甲醚等二醇化合物的單醚體; 乙二醇二乙醚、乙二醇二丁醚、二乙二醇二甲醚、二乙二醇乙基甲基醚(以下簡記為「EDM」)、二乙二醇丁基甲基醚、二乙二醇二乙醚、二丙二醇二甲醚、三乙二醇二甲醚等二醇化合物的二醚體; 乙二醇單甲醚乙酸酯、乙二醇單乙醚乙酸酯、乙二醇單丁醚乙酸酯、丙二醇單甲醚乙酸酯(以下簡記為「PGMEA」)、丙二醇單乙醚乙酸酯、丁二醇單甲醚乙酸酯、二乙二醇單乙醚乙酸酯、二乙二醇單丁醚乙酸酯、二丙二醇單甲醚乙酸酯等二醇化合物的單醚單酯體; 乙二醇二乙酸酯、丙二醇二乙酸酯等二醇化合物的二酯體; 乙酸丁酯、丙酸丁酯、丁酸甲酯、丁酸乙酯、丁酸丁酯等單羧酸化合物的單酯體; 甲氧基乙酸甲酯、甲氧基乙酸乙酯、3-甲氧基丙酸甲酯(以下簡記為「MMP」)、3-乙氧基丙酸乙酯、3-乙氧基丙酸乙酯、4-甲氧基丁酸甲酯等單羥基羧酸化合物的單醚單酯體; 琥珀酸二甲酯、琥珀酸二乙酯等二羧酸化合物的二酯體; N,N-二甲基乙醯胺、N,N-二甲基丙醯胺等單羧酸化合物的單醯胺體; 甲基異丁基酮、甲基正丁基酮、二乙基酮、乙基異丁基酮、二異丁基酮、二正丁基酮等二烷基酮化合物; 環氧己烷(hexamethylene oxide)、1,4-二噁烷等環狀醚化合物; β-丙內酯、γ-丁內酯、δ-戊內酯等環狀酯化合物; 2-吡咯烷酮、N-甲基-2-吡咯烷酮等環狀醯胺化合物;及 環戊酮(以下簡記為「CPN」)、環己酮、環庚酮等環狀酮化合物。可使用這些化合物中的一種以上。<1-1-4. Specific examples of synthetic solvents> Specific examples of synthetic solvents are glycol compounds such as ethylene glycol, propylene glycol, butylene glycol, diethylene glycol, dipropylene glycol, and triethylene glycol; Ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monobutyl ether, propylene glycol monomethyl ether (hereinafter abbreviated as "PGME"), propylene glycol monoethyl ether, propylene glycol monobutyl ether (hereinafter abbreviated as "PGBE"), Monoethers of glycol compounds such as butanediol monomethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monobutyl ether, dipropylene glycol monomethyl ether, triethylene glycol monomethyl ether body; Ethylene glycol diethyl ether, ethylene glycol dibutyl ether, diethylene glycol dimethyl ether, diethylene glycol ethyl methyl ether (hereinafter abbreviated as "EDM"), diethylene glycol butyl methyl ether, diethylene glycol Diether body of glycol compounds such as alcohol diethyl ether, dipropylene glycol dimethyl ether, triethylene glycol dimethyl ether; Ethylene glycol monomethyl ether acetate, ethylene glycol monoethyl ether acetate, ethylene glycol monobutyl ether acetate, propylene glycol monomethyl ether acetate (hereinafter abbreviated as "PGMEA"), propylene glycol monoethyl ether acetate Monoether monoesters of glycol compounds such as esters, butylene glycol monomethyl ether acetate, diethylene glycol monoethyl ether acetate, diethylene glycol monobutyl ether acetate, dipropylene glycol monomethyl ether acetate body; Diesters of glycol compounds such as ethylene glycol diacetate and propylene glycol diacetate; Monoesters of monocarboxylic acid compounds such as butyl acetate, butyl propionate, methyl butyrate, ethyl butyrate, butyl butyrate; Methyl methoxyacetate, ethyl methoxyacetate, methyl 3-methoxypropionate (hereinafter abbreviated as "MMP"), ethyl 3-ethoxypropionate, ethyl 3-ethoxypropionate Monoether monoesters of monohydroxy carboxylic acid compounds such as esters and methyl 4-methoxybutyrate; Diesters of dicarboxylic acid compounds such as dimethyl succinate and diethyl succinate; Monoamide body of monocarboxylic acid compounds such as N,N-dimethylacetamide, N,N-dimethylpropylamide; Dialkyl ketone compounds such as methyl isobutyl ketone, methyl n-butyl ketone, diethyl ketone, ethyl isobutyl ketone, diisobutyl ketone, and di-n-butyl ketone; Cyclic ether compounds such as hexamethylene oxide and 1,4-dioxane; β-propiolactone, γ-butyrolactone, δ-valerolactone and other cyclic ester compounds; Cyclic amide compounds such as 2-pyrrolidone and N-methyl-2-pyrrolidone; and Cyclic ketone compounds such as cyclopentanone (hereinafter abbreviated as "CPN"), cyclohexanone, and cycloheptanone. One or more of these compounds can be used.

這些合成溶劑的具體例中,就醯亞胺化合物(A)的溶解性高的方面而言,優選為二醇化合物的單醚體、二醇化合物的二醚體、二醇化合物的單醚單酯體及單羥基羧酸化合物的單醚單酯體。Among the specific examples of these synthetic solvents, in terms of high solubility of the amide imine compound (A), monoethers of glycol compounds, diethers of glycol compounds, and monoethers of glycol compounds are preferred Ester body and monoether monoester body of monohydroxy carboxylic acid compound.

<1-1-5.醯亞胺化合物(A)的分子量> 所獲得的醯亞胺化合物(A)的重量平均分子量優選為500~500,000,更優選為1,000~50,000。若為所述範圍,則醯亞胺化合物(A)相對於多官能羧基化合物(B)及多官能環氧化合物(C)的相容性良好。<1-1-5. Molecular weight of the amide imine compound (A)> The weight average molecular weight of the obtained imide compound (A) is preferably 500 to 500,000, and more preferably 1,000 to 50,000. Within the above range, the amide imine compound (A) has good compatibility with the polyfunctional carboxyl compound (B) and the polyfunctional epoxy compound (C).

本說明書中的重量平均分子量為通過凝膠滲透色譜法(Gel Permeation Chromatography,GPC)(管柱溫度:35℃,流速:1 mL/min)而求出的聚苯乙烯換算的值。標準的聚苯乙烯使用分子量為645~132,900的聚苯乙烯(例如,安捷倫科技(Agilent Technologies)股份有限公司的聚苯乙烯校準套組(calibration kit)PL2010-0102),管柱使用PLgel MIXED-D(商品名,安捷倫科技(Agilent Technologies)股份有限公司),可使用四氫呋喃作為流動相而進行測定。再者,本說明書中的市售品的重量平均分子量為目錄(catalogue)記載值。The weight average molecular weight in this specification is a value converted from polystyrene calculated by gel permeation chromatography (Gel Permeation Chromatography, GPC) (column temperature: 35°C, flow rate: 1 mL/min). Standard polystyrene uses polystyrene with a molecular weight of 645 to 132,900 (for example, Agilent Technologies' polystyrene calibration kit (PL2010-0102), and the column uses PLgel MIXED-D (Trade name, Agilent Technologies, Inc.), can be measured using tetrahydrofuran as the mobile phase. In addition, the weight average molecular weight of the commercial item in this specification is the value described in a catalog.

<1-2.多官能羧基化合物(B)> 本發明中所使用的多官能羧基化合物(B)為每一分子具有三個以上的羧基的化合物。<1-2. Multifunctional carboxyl compound (B)> The polyfunctional carboxyl compound (B) used in the present invention is a compound having three or more carboxyl groups per molecule.

優選的多官能羧基化合物(B)的例子是通過將四羧酸二酐(b11)、二胺(b12)及多元羥基化合物(b13)設為必需原料並加以反應而獲得的聚酯醯胺酸(B1)。所述化合物的原料的獲取或化合物的製造容易,且含有所述化合物的硬化性組成物相對於醯亞胺化合物(A)及多官能環氧化合物(C)的相容性良好。An example of a preferable polyfunctional carboxyl compound (B) is polyester amide acid obtained by reacting tetracarboxylic dianhydride (b11), diamine (b12) and polyhydroxy compound (b13) as essential raw materials and reacting them. (B1). The raw material of the compound is easily obtained or the production of the compound is easy, and the curable composition containing the compound has good compatibility with the amide imine compound (A) and the polyfunctional epoxy compound (C).

<1-2-1.聚酯醯胺酸(B1)> 本發明中所使用的聚酯醯胺酸(B1)是通過將四羧酸二酐(b11)、二胺(b12)及多元羥基化合物(b13)作為必需原料並加以反應而獲得的反應產物。進而,除這些成分以外,也可將選自一元醇(b14)及苯乙烯-馬來酸酐共聚物(b15)中的一種以上添加於原料中。<1-2-1. Polyesteramide (B1)> The polyester amide acid (B1) used in the present invention is a reaction product obtained by reacting tetracarboxylic dianhydride (b11), diamine (b12), and polyhydroxy compound (b13) as necessary raw materials. Furthermore, in addition to these components, one or more kinds selected from monohydric alcohol (b14) and styrene-maleic anhydride copolymer (b15) may be added to the raw material.

將聚酯醯胺酸(B1)添加於本發明的硬化性組成物中的方法可直接添加聚合反應後的溶液,也可對所述溶液進行濃縮而取出固體成分,從而僅添加固體成分。The method of adding polyester amide acid (B1) to the curable composition of the present invention may directly add the solution after the polymerization reaction, or may concentrate the solution to take out the solid content, thereby adding only the solid content.

<1-2-1-1.四羧酸二酐(b11)> 本發明中所使用的四羧酸二酐(b11)的例子為芳香族四羧酸二酐、脂環式四羧酸二酐及脂肪族四羧酸二酐。<1-2-1-1. Tetracarboxylic dianhydride (b11)> Examples of the tetracarboxylic dianhydride (b11) used in the present invention are aromatic tetracarboxylic dianhydride, alicyclic tetracarboxylic dianhydride, and aliphatic tetracarboxylic dianhydride.

芳香族四羧酸二酐的具體例為3,3',4,4'-二苯甲酮四羧酸二酐、2,2',3,3'-二苯甲酮四羧酸二酐、2,3,3',4'-二苯甲酮四羧酸二酐、3,3',4,4'-二苯基碸四羧酸二酐、2,2',3,3'-二苯基碸四羧酸二酐、2,3,3',4'-二苯基碸四羧酸二酐、3,3',4,4'-二苯基醚四羧酸二酐、2,2',3,3'-二苯基醚四羧酸二酐、2,3,3',4'-二苯基醚四羧酸二酐、2,2-[雙(3,4-二羧基苯基)]六氟丙烷二酐及乙二醇雙(脫水偏苯三酸酯);脂環式四羧酸二酐的具體例為環丁烷四羧酸二酐、甲基環丁烷四羧酸二酐、環戊烷四羧酸二酐及環己烷四羧酸二酐;脂肪族四羧酸二酐的具體例為乙烷四羧酸二酐及丁烷四羧酸二酐。Specific examples of aromatic tetracarboxylic dianhydride are 3,3',4,4'-benzophenone tetracarboxylic dianhydride, 2,2',3,3'-benzophenone tetracarboxylic dianhydride , 2,3,3',4'-benzophenone tetracarboxylic dianhydride, 3,3',4,4'-diphenyl ash tetracarboxylic dianhydride, 2,2',3,3' -Diphenyl sulfone tetracarboxylic dianhydride, 2,3,3',4'-diphenyl sulfone tetracarboxylic dianhydride, 3,3',4,4'-diphenyl ether tetracarboxylic dianhydride , 2,2',3,3'-diphenyl ether tetracarboxylic dianhydride, 2,3,3',4'-diphenyl ether tetracarboxylic dianhydride, 2,2-[bis(3, 4-dicarboxyphenyl)] hexafluoropropane dianhydride and ethylene glycol bis (dehydrated trimellitate); specific examples of alicyclic tetracarboxylic dianhydride are cyclobutane tetracarboxylic dianhydride, methyl Cyclobutane tetracarboxylic dianhydride, cyclopentane tetracarboxylic dianhydride and cyclohexane tetracarboxylic dianhydride; specific examples of aliphatic tetracarboxylic dianhydride are ethane tetracarboxylic dianhydride and butane tetracarboxylic acid Acid dianhydride.

這些四羧酸二酐中,優選為3,3',4,4'-二苯基碸四羧酸二酐、3,3',4,4'-二苯基醚四羧酸二酐、2,2-[雙(3,4-二羧基苯基)]六氟丙烷二酐、乙二醇雙(脫水偏苯三酸酯)及丁烷四羧酸二酐,更優選為3,3',4,4'-二苯基碸四羧酸二酐、3,3',4,4'-二苯基醚四羧酸二酐及丁烷四羧酸二酐。由含有聚酯醯胺酸(B1)的硬化性組成物獲得的硬化膜的透明性高,所述聚酯醯胺酸(B1)是由包含選自這些四羧酸二酐中的一種以上的原料獲得。Among these tetracarboxylic dianhydrides, 3,3',4,4'-diphenyl sulfone tetracarboxylic dianhydride, 3,3',4,4'-diphenyl ether tetracarboxylic dianhydride, 2,2-[bis(3,4-dicarboxyphenyl)] hexafluoropropane dianhydride, ethylene glycol bis (dehydrated trimellitate) and butane tetracarboxylic dianhydride, more preferably 3,3 ',4,4'-diphenylbenzene tetracarboxylic dianhydride, 3,3',4,4'-diphenyl ether tetracarboxylic dianhydride and butane tetracarboxylic dianhydride. The cured film obtained from the curable composition containing polyester amide acid (B1) is high in transparency, and the polyester amide acid (B1) is composed of one or more kinds selected from these tetracarboxylic dianhydrides Raw materials obtained.

四羧酸二酐(b11)可單獨使用所述化合物,也可將兩種以上混合而使用。The tetracarboxylic dianhydride (b11) may be used alone or in combination of two or more.

<1-2-1-2.二胺(b12)> 本發明中所使用的二胺(b12)的例子為具有兩個苯環的二胺及具有四個苯環的二胺。<1-2-1-2. Diamine (b12)> Examples of the diamine (b12) used in the present invention are a diamine having two benzene rings and a diamine having four benzene rings.

具有兩個苯環的二胺的具體例為3,3'-二氨基二苯基碸、4,4'-二氨基二苯基碸及3,4'-二氨基二苯基碸;具有四個苯環的二胺的具體例為雙[4-(4-氨基苯氧基)苯基]碸、雙[4-(3-氨基苯氧基)苯基]碸、雙[3-(4-氨基苯氧基)苯基]碸、[4-(4-氨基苯氧基)苯基][3-(4-氨基苯氧基)苯基]碸、[4-(3-氨基苯氧基)苯基][3-(4-氨基苯氧基)苯基]碸及2,2-雙[4-(4-氨基苯氧基)苯基]六氟丙烷。Specific examples of diamines having two benzene rings are 3,3'-diaminodiphenyl sulfone, 4,4'-diaminodiphenyl ash and 3,4'-diaminodiphenyl ash; with four Specific examples of the diamines of each benzene ring are bis[4-(4-aminophenoxy)phenyl] phenanthrene, bis[4-(3-aminophenoxy)phenyl] phenanthrene, bis[3-(4 -Aminophenoxy)phenyl] phenanthrene, [4-(4-aminophenoxy)phenyl][3-(4-aminophenoxy)phenyl] phenanthrene, [4-(3-aminophenoxy Group) phenyl][3-(4-aminophenoxy)phenyl] benzene and 2,2-bis[4-(4-aminophenoxy)phenyl]hexafluoropropane.

這些二胺中,優選為3,3'-二氨基二苯基碸。由包含所述二胺的原料獲得的聚酯醯胺酸(B1)對溶劑的溶解性良好。Among these diamines, 3,3′-diaminodiphenylbenzene is preferred. The polyester amide acid (B1) obtained from the raw material containing the diamine has good solubility in solvents.

二胺(b12)可單獨使用所述化合物,也可將兩種以上混合而使用。The diamine (b12) may be used alone or in combination of two or more.

<1-2-1-3.多元羥基化合物(b13)> 本發明中所使用的多元羥基化合物(b13)的具體例為乙二醇、二乙二醇、三乙二醇、四乙二醇、重量平均分子量為1,000以下的聚乙二醇、丙二醇、二丙二醇、三丙二醇、四丙二醇、重量平均分子量為1,000以下的聚丙二醇、1,2-丁二醇、1,3-丁二醇、1,4-丁二醇、1,2-戊二醇、1,5-戊二醇、2,4-戊二醇、1,2,5-戊三醇、1,2-己二醇、1,6-己二醇、2,5-己二醇、1,2,6-己三醇、1,2-庚二醇、1,7-庚二醇、1,2,7-庚三醇、1,2-辛二醇、1,8-辛二醇、3,6-辛二醇、1,2,8-辛三醇、1,2-壬二醇、1,9-壬二醇、1,2,9-壬三醇、1,2-癸二醇、1,10-癸二醇、1,2,10-癸三醇、1,2-十二烷二醇、1,12-十二烷二醇、甘油、三羥甲基丙烷、季戊四醇、二季戊四醇、雙酚A、雙酚S、雙酚F、二乙醇胺及三乙醇胺。<1-2-1-3. Polyhydroxy compound (b13)> Specific examples of the polyhydric hydroxy compound (b13) used in the present invention are ethylene glycol, diethylene glycol, triethylene glycol, tetraethylene glycol, polyethylene glycol with a weight average molecular weight of 1,000 or less, propylene glycol, and diethylene glycol. Propylene glycol, tripropylene glycol, tetrapropylene glycol, polypropylene glycol with a weight average molecular weight of 1,000 or less, 1,2-butanediol, 1,3-butanediol, 1,4-butanediol, 1,2-pentanediol, 1,5-pentanediol, 2,4-pentanediol, 1,2-pentanetriol, 1,2-hexanediol, 1,6-hexanediol, 2,5-hexanediol, 1,2,6-hexanetriol, 1,2-heptanediol, 1,7-heptanediol, 1,2,7-heptanetriol, 1,2-octanediol, 1,8-octanediol Alcohol, 3,6-octanediol, 1,2,8-octanetriol, 1,2-nonandiol, 1,9-nonandiol, 1,2,9-nonanetriol, 1,2- Decanediol, 1,10-decanediol, 1,2,10-decanetriol, 1,2-dodecanediol, 1,12-dodecanediol, glycerin, trimethylolpropane, Pentaerythritol, dipentaerythritol, bisphenol A, bisphenol S, bisphenol F, diethanolamine and triethanolamine.

這些化合物中,優選為乙二醇、丙二醇、1,4-丁二醇、1,5-戊二醇、1,6-己二醇、1,7-庚二醇及1,8-辛二醇,更優選為1,4-丁二醇、1,5-戊二醇及1,6-己二醇。由包含選自這些化合物中的一種以上的原料獲得的聚酯醯胺酸(B1)對溶劑的溶解性良好。Among these compounds, preferred are ethylene glycol, propylene glycol, 1,4-butanediol, 1,5-pentanediol, 1,6-hexanediol, 1,7-heptanediol and 1,8-octanediol The alcohol is more preferably 1,4-butanediol, 1,5-pentanediol, and 1,6-hexanediol. The polyester amide acid (B1) obtained from one or more raw materials selected from these compounds has good solubility in solvents.

多元羥基化合物(b13)可單獨使用所述化合物,也可將兩種以上混合而使用。The polyhydric hydroxy compound (b13) may be used alone or in combination of two or more.

<1-2-1-4.一元醇(b14)> 聚酯醯胺酸(B1)的合成中,除四羧酸二酐(b11)、二胺(b12)及多元羥基化合物(b13)以外,也可進一步使一元醇(b14)進行反應。<1-2-1-4. Monohydric alcohol (b14)> In the synthesis of polyester amide acid (B1), in addition to tetracarboxylic dianhydride (b11), diamine (b12), and polyhydroxy compound (b13), a monohydric alcohol (b14) may be further reacted.

一元醇(b14)的具體例為甲醇、乙醇、1-丙醇、異丙醇、烯丙醇、苄醇、甲基丙烯酸羥基乙酯、丙二醇單乙醚、丙二醇單甲醚、二丙二醇單乙醚、二丙二醇單甲醚、乙二醇單乙醚、乙二醇單甲醚、二乙二醇單乙醚、二乙二醇單甲醚、苯酚、冰片(borneol)、麥芽醇(maltol)、沉香醇(linalool)、萜品醇(terpineol)、二甲基苄基甲醇、3-乙基-3-羥基甲基氧雜環丁烷。Specific examples of the monohydric alcohol (b14) are methanol, ethanol, 1-propanol, isopropanol, allyl alcohol, benzyl alcohol, hydroxyethyl methacrylate, propylene glycol monoethyl ether, propylene glycol monomethyl ether, dipropylene glycol monoethyl ether, Dipropylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monomethyl ether, phenol, borneol (borneol), maltol (maltol), linalool (Linalool), terpineol (terpineol), dimethylbenzyl methanol, 3-ethyl-3-hydroxymethyloxetane.

這些化合物中,優選為異丙醇、烯丙醇、苄醇、甲基丙烯酸羥基乙酯、丙二醇單乙醚及3-乙基-3-羥基甲基氧雜環丁烷,更優選為苄醇。由包含選自這些化合物中的一種以上的原料獲得的聚酯醯胺酸(B1)相對於多官能環氧化合物(C)的相容性良好。Among these compounds, isopropyl alcohol, allyl alcohol, benzyl alcohol, hydroxyethyl methacrylate, propylene glycol monoethyl ether, and 3-ethyl-3-hydroxymethyloxetane are preferred, and benzyl alcohol is more preferred. The polyester amide acid (B1) obtained from one or more raw materials selected from these compounds has good compatibility with the polyfunctional epoxy compound (C).

一元醇(b14)可單獨使用所述化合物,也可將兩種以上混合而使用。The monohydric alcohol (b14) may be used alone or in combination of two or more.

<1-2-1-5.苯乙烯-馬來酸酐共聚物(b15)> 聚酯醯胺酸(B1)的合成中,除四羧酸二酐(b11)、二胺(b12)及多元羥基化合物(b13)以外,也可使苯乙烯-馬來酸酐共聚物(b15)進行反應。<1-2-1-5. Styrene-maleic anhydride copolymer (b15)> In the synthesis of polyester amide acid (B1), in addition to tetracarboxylic dianhydride (b11), diamine (b12) and polyhydroxy compound (b13), styrene-maleic anhydride copolymer (b15) can also be used React.

通過添加苯乙烯-馬來酸酐共聚物(b15),可提高聚酯醯胺酸(B1)相對於多官能環氧化合物(C)的相容性。苯乙烯/馬來酸酐的莫耳比為0.5~4,優選為1~3,具體而言,更優選為約1、約2或約3,進而優選為約1或約2,特別優選為約1。By adding the styrene-maleic anhydride copolymer (b15), the compatibility of the polyester amide acid (B1) with respect to the multifunctional epoxy compound (C) can be improved. The molar ratio of styrene/maleic anhydride is 0.5 to 4, preferably 1 to 3, specifically, more preferably about 1, about 2 or about 3, further preferably about 1 or about 2, and particularly preferably about 1.

苯乙烯-馬來酸酐共聚物(b15)的市售品的具體例為SMA1000、SMA2000及SMA3000(均為商品名,川原油化股份有限公司)。這些具體例中,優選為對溶劑的溶解性良好的SMA1000。Specific examples of commercially available products of styrene-maleic anhydride copolymer (b15) are SMA1000, SMA2000, and SMA3000 (all are trade names, Chuan Crude Oil Chemical Co., Ltd.). Among these specific examples, SMA1000 having good solubility in solvents is preferable.

苯乙烯-馬來酸酐共聚物(b15)可單獨使用所述化合物,也可將兩種以上混合而使用。The styrene-maleic anhydride copolymer (b15) may be used alone or in combination of two or more.

<1-2-1-6.聚酯醯胺酸(B1)的聚合方法> 本發明中所使用的聚酯醯胺酸(B1)可利用已知的聚合方法來製造(例如,在日本專利特開2015-163685中有記載)。優選的聚合方法為使用用於聚合反應中的溶劑(以下表述為「聚合溶劑」)的溶液聚合。<1-2-1-6. Polymerization method of polyester amide acid (B1)> The polyester amide acid (B1) used in the present invention can be produced by a known polymerization method (for example, described in Japanese Patent Laid-Open No. 2015-163685). A preferred polymerization method is solution polymerization using a solvent (hereinafter referred to as "polymerization solvent") used in the polymerization reaction.

<1-3.多官能環氧化合物(C)> 本發明中所使用的多官能環氧化合物(C)為每一分子具有三個以上的環氧基的化合物。<1-3. Multifunctional epoxy compound (C)> The multifunctional epoxy compound (C) used in the present invention is a compound having three or more epoxy groups per molecule.

本發明中所使用的多官能環氧化合物(C)的例子為 苯酚酚醛清漆型環氧化合物、甲酚酚醛清漆型環氧化合物、雙酚A酚醛清漆型環氧化合物、聯苯型多官能環氧化合物、具有矽氧烷鍵結部位的多官能環氧化合物、2-[4-(2,3-環氧丙氧基)苯基]-2-[4-[1,1-雙[4-(2,3-環氧丙氧基)苯基]乙基]苯基]丙烷、1,3-雙[4-[1-[4-(2,3-環氧丙氧基)苯基]-1-[4-[1-[4-(2,3-環氧丙氧基)苯基]-1-甲基乙基]苯基]乙基]苯氧基]-2-丙醇及α-2,3-環氧丙氧基苯基-w-氫聚[2-(2,3-環氧丙氧基)亞苄基-2,3-環氧丙氧基亞苯基]等具有三個以上的縮水甘油醚基的化合物; 甲基丙烯酸縮水甘油酯的均聚物、甲基丙烯酸縮水甘油酯及甲基丙烯酸縮水甘油酯以外的聚合性化合物的共聚物等具有三個以上的縮水甘油酯基的化合物;及 2,2-雙(羥基甲基)-1-丁醇的1,2-環氧基-4-(2-氧雜環丙基)環己烷加成物等具有三個以上的氧雜環丙基的化合物。Examples of the multifunctional epoxy compound (C) used in the present invention are Phenol novolac epoxy compound, cresol novolac epoxy compound, bisphenol A novolac epoxy compound, biphenyl polyfunctional epoxy compound, polyfunctional epoxy compound with a siloxane bond site, 2-[4-(2,3-epoxypropyloxy)phenyl]-2-[4-[1,1-bis[4-(2,3-epoxypropyloxy)phenyl]ethyl ]Phenyl]propane, 1,3-bis[4-[1-[4-(2,3-epoxypropoxy)phenyl]-1-[4-[1-[4-(2,3 -Glycidoxy)phenyl]-1-methylethyl]phenyl]ethyl]phenoxy]-2-propanol and α-2,3-glycidoxyphenyl-w- Hydropoly[2-(2,3-glycidoxy)benzylidene-2,3-glycidoxyoxyphenylene] and other compounds with more than three glycidyl ether groups; Compounds having three or more glycidyl groups, such as homopolymers of glycidyl methacrylate, copolymers of glycidyl methacrylate and polymerizable compounds other than glycidyl methacrylate, and the like; and 1,2-epoxy-4-(2-oxepropyl) cyclohexane adducts of 2,2-bis(hydroxymethyl)-1-butanol have three or more oxygen heterocycles Propyl compounds.

包含具有三個以上的縮水甘油醚基的化合物的硬化性組成物提供耐熱性良好的硬化膜,包含具有三個以上的縮水甘油酯基的化合物的硬化性組成物在煆燒溫度低的情況下也提供耐化學品性良好的硬化膜,包含具有三個以上的氧雜環丙基的化合物的硬化性組成物提供耐UV性良好的硬化膜。A curable composition containing a compound having three or more glycidyl ether groups provides a cured film with good heat resistance, and a curable composition containing a compound having three or more glycidyl ester groups when the burning temperature is low A cured film with good chemical resistance is also provided, and a curable composition containing a compound having three or more oxetanyl groups provides a cured film with good UV resistance.

具有三個以上的縮水甘油醚基的化合物中,特別優選為提供耐熱性特別良好的硬化膜的雙酚A酚醛清漆型環氧化合物、2-[4-(2,3-環氧丙氧基)苯基]-2-[4-[1,1-雙[4-(2,3-環氧丙氧基)苯基]乙基]苯基]丙烷、1,3-雙[4-[1-[4-(2,3-環氧丙氧基)苯基]-1-[4-[1-[4-(2,3-環氧丙氧基)苯基]-1-甲基乙基]苯基]乙基]苯氧基]-2-丙醇及α-2,3-環氧丙氧基苯基-w-氫聚[2-(2,3-環氧丙氧基)亞苄基-2,3-環氧丙氧基亞苯基]。Among the compounds having three or more glycidyl ether groups, bisphenol A novolac-type epoxy compounds and 2-[4-(2,3-epoxypropoxy) that provide cured films with particularly good heat resistance are particularly preferred )Phenyl]-2-[4-[1,1-bis[4-(2,3-epoxypropoxy)phenyl]ethyl]phenyl]propane, 1,3-bis[4-[ 1-[4-(2,3-epoxypropyloxy)phenyl]-1-[4-[1-[4-(2,3-epoxypropyloxy)phenyl]-1-methyl Ethyl]phenyl]ethyl]phenoxy]-2-propanol and α-2,3-glycidoxy phenyl-w-hydropoly[2-(2,3-glycidoxy) ) Benzylidene-2,3-glycidoxyphenylene].

苯酚酚醛清漆型環氧化合物的市售品的具體例為EPPN-201(商品名,日本化藥股份有限公司)及jER 152、jER 154(均為商品名,三菱化學股份有限公司);甲酚酚醛清漆型環氧化合物的市售品的具體例為EOCN-102S、EOCN-103S、EOCN-104S、EOCN-1020(均為商品名,日本化藥股份有限公司);雙酚A酚醛清漆型環氧化合物的市售品的具體例為jER 157S65、jER 157S70(均為商品名,三菱化學股份有限公司);聯苯型多官能環氧化合物的市售品的具體例為NC-3000、NC-3000-L、NC-3000-H、NC-3100(均為商品名,日本化藥股份有限公司);具有矽氧烷鍵結部位的多官能環氧化合物的市售品的具體例為考特奧斯陸(COATOSIL)MP200(商品名,日本邁圖高新材料(Momentive Performance Materials Japan)有限責任公司)、空珀塞朗(Conpoceran)SQ506(商品名,荒川化學股份有限公司)、ES-1023(商品名,信越化學工業股份有限公司);包含2-[4-(2,3-環氧丙氧基)苯基]-2-[4-[1,1-雙[4-(2,3-環氧丙氧基)苯基]乙基]苯基]丙烷及1,3-雙[4-[1-[4-(2,3-環氧丙氧基)苯基]-1-[4-[1-[4-(2,3-環氧丙氧基)苯基]-1-甲基乙基]苯基]乙基]苯氧基]-2-丙醇的市售品的具體例為特克莫(TECHMORE)VG3101L(商品名,普林泰科(Printec)股份有限公司);α-2,3-環氧丙氧基苯基-w-氫聚[2-(2,3-環氧丙氧基)亞苄基-2,3-環氧丙氧基亞苯基]的市售品的具體例為EPPN-501H、EPPN-502H(均為商品名,日本化藥股份有限公司);甲基丙烯酸縮水甘油酯的均聚物的具體例為瑪普魯富(MARPROOF)G-01100(商品名,日油股份有限公司);2,2-雙(羥基甲基)-1-丁醇的1,2-環氧基-4-(2-氧雜環丙基)環己烷加成物的市售品的具體例為EHPE3150(商品名,大賽璐(Daicel)股份有限公司)。Specific examples of commercially available products of phenol novolac epoxy compounds are EPPN-201 (trade name, Nippon Kayaku Co., Ltd.) and jER 152, jER 154 (both trade names, Mitsubishi Chemical Co., Ltd.); cresol Specific examples of commercially available products of novolac epoxy compounds are EOCN-102S, EOCN-103S, EOCN-104S, and EOCN-1020 (all are trade names, Nippon Kayaku Co., Ltd.); bisphenol A novolac type ring Specific examples of commercially available products of oxygen compounds are jER 157S65 and jER 157S70 (both trade names, Mitsubishi Chemical Corporation); specific examples of commercially available products of biphenyl type polyfunctional epoxy compounds are NC-3000 and NC- 3000-L, NC-3000-H, NC-3100 (all are trade names, Nippon Kayaku Co., Ltd.); a specific example of a commercially available product of a polyfunctional epoxy compound having a siloxane bond site is Court Oslo (COATOSIL) MP200 (trade name, Japan Momentive Performance Materials Japan Co., Ltd.), Conpoceran (Conpoceran) SQ506 (trade name, Arakawa Chemical Co., Ltd.), ES-1023 (trade name , Shin-Etsu Chemical Industry Co., Ltd.); contains 2-[4-(2,3-epoxypropoxy)phenyl]-2-[4-[1,1-bis[4-(2,3-ring Oxypropyloxy)phenyl]ethyl]phenyl]propane and 1,3-bis[4-[1-[4-(2,3-epoxypropoxy)phenyl]-1-[4- Specific examples of commercially available products of [1-[4-(2,3-epoxypropoxy)phenyl]-1-methylethyl]phenyl]ethyl]phenoxy]-2-propanol TECHMORE VG3101L (trade name, Printec Co., Ltd.); α-2,3-epoxypropoxyphenyl-w-hydropoly[2-(2,3- Specific examples of commercially available products of glycidoxy)benzylidene-2,3-glycidoxyoxyphenylene] are EPPN-501H and EPPN-502H (all are trade names, Nippon Kayaku Co., Ltd. ); A specific example of a homopolymer of glycidyl methacrylate is MARPROOF G-01100 (trade name, Nippon Oil Co., Ltd.); 2,2-bis(hydroxymethyl)-1- A specific example of a commercially available product of 1,2-epoxy-4-(2-oxepropyl)cyclohexane adduct of butanol is EHPE3150 (trade name, Daicel Co., Ltd.) .

<1-4.添加劑(D)> 本發明的硬化性組成物也可還含有添加劑(D)。就提高塗布均勻性、密接性、穩定性、耐化學品性及低溫硬化性等本發明的硬化性組成物的特性的觀點而言,可添加本發明的硬化性組成物中所任意添加的添加劑(D)。<1-4. Additives (D)> The curable composition of the present invention may further contain additives (D). From the viewpoint of improving the characteristics of the curable composition of the present invention, such as coating uniformity, adhesion, stability, chemical resistance, and low-temperature curability, additives arbitrarily added to the curable composition of the present invention may be added (D).

添加劑(D)的例子為陰離子系、陽離子系、非離子系及氟系的表面活性劑;矽酮樹脂系塗布性提高劑;矽烷系偶聯劑等密接性提高劑;聚丙烯酸鈉等防凝聚劑;丙烯酸系、苯乙烯系、聚乙烯亞胺系及氨基甲酸酯系等高分子分散劑;受阻系酚等抗氧化劑;多官能環氧化合物(C)以外的環氧化合物、三聚氰胺化合物及雙疊氮化合物等交聯劑;光酸產生劑;多官能(甲基)丙烯酸酯化合物;及光聚合起始劑。Examples of additives (D) are anionic, cationic, nonionic and fluorine-based surfactants; silicone resin-based coating improvers; silane-based coupling agents and other adhesion improvers; sodium polyacrylate and other anti-agglomeration Agents; acrylic, styrene, polyethyleneimine, and urethane polymer dispersants; hindered phenolic antioxidants; epoxy compounds other than polyfunctional epoxy compounds (C), melamine compounds, and Cross-linking agents such as diazide compounds; photoacid generators; polyfunctional (meth)acrylate compounds; and photopolymerization initiators.

<1-4-1.表面活性劑> 就進一步提高塗布均勻性的觀點而言,本發明的硬化性組成物也可還含有表面活性劑。表面活性劑的具體例為波利弗洛(Polyflow)No.75、波利弗洛(Polyflow)No.90、波利弗洛(Polyflow)No.95(均為商品名,共榮社化學股份有限公司)、迪斯帕畢克(DISPERBYK)-161、迪斯帕畢克(DISPERBYK)-162、迪斯帕畢克(DISPERBYK)-163、迪斯帕畢克(DISPERBYK)-164、迪斯帕畢克(DISPERBYK)-166、迪斯帕畢克(DISPERBYK)-170、迪斯帕畢克(DISPERBYK)-180、迪斯帕畢克(DISPERBYK)-181、迪斯帕畢克(DISPERBYK)-182、BYK-300、BYK-306、BYK-310、BYK-320、BYK-330、BYK-342、BYK-346、BYK-361N、BYK-UV3500、BYK-UV3570(均為商品名,日本畢克化學(BYK Chemie Japan)股份有限公司)、KP-341、KP-368、KF-96-50CS、KF-50-100CS(均為商品名,信越化學工業股份有限公司)、沙福隆(Surflon)S611(商品名,AGC清美化學(AGC Seimi Chemical)股份有限公司)、福吉特(Ftergent)222F、福吉特(Ftergent)208G、福吉特(Ftergent)251、福吉特(Ftergent)710FL、福吉特(Ftergent)710FM、福吉特(Ftergent)710FS、福吉特(Ftergent)601AD、福吉特(Ftergent)650A、FTX-218(均為商品名,尼奧斯(Neos)股份有限公司)、美佳法(Megafac)F-171、美佳法(Megafac)F-177、美佳法(Megafac)F-410、美佳法(Megafac)F-430、美佳法(Megafac)F-444、美佳法(Megafac)F-472SF、美佳法(Megafac)F-475、美佳法(Megafac)F-477、美佳法(Megafac)F-552、美佳法(Megafac)F-553、美佳法(Megafac)F-554、美佳法(Megafac)F-555、美佳法(Megafac)F-556、美佳法(Megafac)F-558、美佳法(Megafac)F-559、美佳法(Megafac)R-94、美佳法(Megafac)RS-75、美佳法(Megafac)RS-72-K、美佳法(Megafac)RS-76-NS、美佳法(Megafac)DS-21(均為商品名,迪愛生(DIC)股份有限公司)、迪高屯(TEGO Twin)4000、迪高屯(TEGO Twin)4100、迪高弗洛(TEGO Flow)370、迪高格萊德(TEGO Glide)440、迪高格萊德(TEGO Glide)450、迪高拉德(TEGO Rad)2200N(均為商品名,日本贏創德固賽(Evonik Degussa Japan)股份有限公司)、氟烷基苯磺酸鹽、氟烷基羧酸鹽、氟烷基聚氧乙烯醚、氟烷基碘化銨、氟烷基甜菜鹼、氟烷基磺酸鹽、二甘油四(氟烷基聚氧乙烯醚)、氟烷基三甲基銨鹽、氟烷基氨基磺酸鹽、聚氧乙烯壬基苯基醚、聚氧乙烯辛基苯基醚、聚氧乙烯烷基醚、聚氧乙烯月桂基醚、聚氧乙烯油烯基醚、聚氧乙烯十三烷基醚、聚氧乙烯鯨蠟基醚、聚氧乙烯硬脂基醚、聚氧乙烯月桂酸酯、聚氧乙烯油酸酯、聚氧乙烯硬脂酸酯、聚氧乙烯月桂基胺、山梨醇酐月桂酸酯、山梨醇酐棕櫚酸酯、山梨醇酐硬脂酸酯、山梨醇酐油酸酯、山梨醇酐脂肪酸酯、聚氧乙烯山梨醇酐月桂酸酯、聚氧乙烯山梨醇酐棕櫚酸酯、聚氧乙烯山梨醇酐硬脂酸酯、聚氧乙烯山梨醇酐油酸酯、聚氧乙烯萘基醚、烷基苯磺酸鹽及烷基二苯基醚二磺酸鹽。可使用這些表面活性劑中的一種以上。<1-4-1. Surfactant> From the viewpoint of further improving coating uniformity, the curable composition of the present invention may further contain a surfactant. Specific examples of surfactants are Polyflow No. 75, Polyflow No. 90, and Polyflow No. 95 (all are trade names, Kyoeisha Chemical Co., Ltd. Co., Ltd.), DISPERBYK-161, DISPERBYK-162, DISPERBYK-163, DISPERBYK-164, DISE DISPERBYK-166, DISPERBYK-170, DISPERBYK-180, DISPERBYK-181, DISPERBYK-181, DISPERBYK -182, BYK-300, BYK-306, BYK-310, BYK-320, BYK-330, BYK-342, BYK-346, BYK-361N, BYK-UV3500, BYK-UV3570 (all are trade names, Japanese Gram Chemical (BYK Chemie Japan) Co., Ltd.), KP-341, KP-368, KF-96-50CS, KF-50-100CS (all trade names, Shin-Etsu Chemical Industry Co., Ltd.), Surflon (Surflon ) S611 (trade name, AGC Seimi Chemical), Ftergent 222F, Ftergent 208G, Ftergent 251, Ftergent 251, Ftergent 710FL, Fujit ( Ftergent) 710FM, Ftergent 710FS, Ftergent 601AD, Ftergent 650A, FTX-218 (all trade names, Neos Co., Ltd.), Megafac F-171, Megafac F-177, Megafac F-410, Megafac F-430, Megafac F-444, Megafac F-472SF, Mega (Megafac) F-475, Megafac F-477, Megafac F-552, Megafac F-553, Megafac F-554, Megafac F -555, Megafac F-556, Megafac F-558, Megafac F-559, Megafac R-94, Megafac RS-75 , Megafac RS-72-K, Megafac RS-76-NS, Megafac DS-21 (all trade names, DIC Co., Ltd.), Digotun (TEGO Twin) 4000, TEGO Twin 4100, TEGO Flow 370, TEGO Glide 440, TEGO Glide 450, Tegola TEGO Rad 2200N (all trade names, Evonik Degussa Japan Co., Ltd.), fluoroalkyl benzene sulfonate, fluoroalkyl carboxylate, fluoroalkyl polyoxyethylene ether , Fluoroalkyl ammonium iodide, fluoroalkyl betaine, fluoroalkyl sulfonate, diglycerol tetrakis (fluoroalkyl polyoxyethylene ether), fluoroalkyl trimethyl ammonium salt, fluoroalkyl sulfamate , Polyoxyethylene nonylphenyl ether, polyoxyethylene octyl phenyl ether, polyoxyethylene alkyl ether, polyoxyethylene lauryl ether, polyoxyethylene oleyl ether, polyoxyethylene tridecyl ether, Polyoxyethylene cetyl ether, polyoxyethylene stearyl ether, polyoxyethylene laurate, polyoxyethylene oleate, polyoxyethylene stearate, polyoxyethylene laurylamine, sorbitan lauric acid Ester, sorbitan palmitate, sorbitan stearate, sorbitan oleate, sorbitan fatty acid ester, polyoxyethylene sorbitan laurate, polyoxyethylene sorbitan palmitate , Polyoxyethylene sorbitan stearate, polyoxyethylene sorbitan oleate, polyoxyethylene naphthyl ether, alkylbenzene sulfonate and alkyl diphenyl ether disulfonate. One or more of these surfactants can be used.

這些表面活性劑的具體例中,若為選自BYK-306、BYK-342、BYK-346、KP-341、KP-368、沙福隆(Surflon)S611、福吉特(Ftergent)710FL、福吉特(Ftergent)710FM、福吉特(Ftergent)710FS、福吉特(Ftergent)650A、美佳法(Megafac)F-477、美佳法(Megafac)F-556、美佳法(Megafac)RS-72-K、美佳法(Megafac)DS-21、迪高屯(TEGO Twin)4000、氟烷基苯磺酸鹽、氟烷基羧酸鹽、氟烷基聚氧乙烯醚、氟烷基磺酸鹽、氟烷基三甲基銨鹽及氟烷基氨基磺酸鹽中的至少一種,則提高硬化性組成物的塗布均勻性的效果大,因此優選。Specific examples of these surfactants are selected from BYK-306, BYK-342, BYK-346, KP-341, KP-368, Surflon S611, Ftergent 710FL, Fujit (Ftergent) 710FM, Ftergent 710FS, Ftergent 650A, Megafac F-477, Megafac F-556, Megafac RS-72-K, Megafa (Megafac) DS-21, TEGO Twin 4000, fluoroalkyl benzene sulfonate, fluoroalkyl carboxylate, fluoroalkyl polyoxyethylene ether, fluoroalkyl sulfonate, fluoroalkyl tri At least one of methyl ammonium salt and fluoroalkyl sulfamate is preferable because it has a large effect of improving the uniformity of application of the curable composition.

相對於主要成分量100重量份,本發明的硬化性組成物中的表面活性劑的添加量優選為0.01重量份~0.1重量份。The addition amount of the surfactant in the curable composition of the present invention is preferably 0.01 to 0.1 parts by weight relative to 100 parts by weight of the main component.

<1-4-2.密接性提高劑> 就進一步提高所形成的硬化膜相對於基材的密接性的觀點而言,本發明的硬化性組成物也可還含有密接性提高劑。密接性提高劑的例子為醯亞胺化合物(A)以外的矽烷系偶聯劑、鋁系偶聯劑及鈦酸酯系偶聯劑。醯亞胺化合物(A)以外的矽烷系偶聯劑的具體例為3-縮水甘油氧基丙基二甲基乙氧基矽烷、3-縮水甘油氧基丙基甲基二乙氧基矽烷、3-縮水甘油氧基丙基三甲氧基矽烷(例如,薩拉艾斯(Sila-Ace)S510;商品名,捷恩智(JNC)股份有限公司)、2-(3,4-環氧環己基)乙基三甲氧基矽烷(例如,薩拉艾斯(Sila-Ace)S530;商品名,捷恩智(JNC)股份有限公司)、3-三甲氧基矽烷基丙基甲基丙烯酸酯(例如,薩拉艾斯(Sila-Ace)S710;商品名,捷恩智(JNC)股份有限公司)、3-巰基丙基三甲氧基矽烷(例如,薩拉艾斯(Sila-Ace)S810;商品名,捷恩智(JNC)股份有限公司),鋁系偶聯劑的具體例為乙醯烷氧基二異丙醇鋁,鈦酸酯系偶聯劑的具體例為四異丙基雙(二辛基亞磷酸酯)鈦酸酯。可使用這些密接性提高劑中的一種以上。<1-4-2. Adhesion improver> From the viewpoint of further improving the adhesion of the formed cured film to the substrate, the curable composition of the present invention may further contain an adhesion improving agent. Examples of the adhesion improving agent are silane-based coupling agents, aluminum-based coupling agents, and titanate-based coupling agents other than the amide imine compound (A). Specific examples of the silane-based coupling agent other than the amide imine compound (A) are 3-glycidoxypropyldimethylethoxysilane, 3-glycidoxypropylmethyldiethoxysilane, 3-glycidoxypropyltrimethoxysilane (for example, Sila-Ace S510; trade name, JNC Co., Ltd.), 2-(3,4-epoxycyclohexyl) ) Ethyltrimethoxysilane (for example, Sila-Ace S530; trade name, JNC Co., Ltd.), 3-trimethoxysilylpropyl methacrylate (for example, Sila-Ace S710; trade name, JNC Co., Ltd., 3-mercaptopropyltrimethoxysilane (for example, Sila-Ace S810; trade name, (JNC) Co., Ltd., the specific example of the aluminum-based coupling agent is aluminum acetoxydiisopropoxide, and the specific example of the titanate-based coupling agent is tetraisopropylbis(dioctyl) Phosphite) titanate. One or more of these adhesion improving agents can be used.

這些密接性提高劑的具體例中,3-縮水甘油氧基丙基三甲氧基矽烷及3-三甲氧基矽烷基丙基甲基丙烯酸酯的提高硬化膜相對於基材的密接性的效果大,因此優選。Among the specific examples of these adhesion-improving agents, 3-glycidoxypropyltrimethoxysilane and 3-trimethoxysilylpropylmethacrylate have a large effect of improving the adhesion of the cured film to the substrate , So preferred.

相對於主要成分量100重量份,本發明的硬化性組成物中的密接性提高劑的添加量優選為0.1重量份~20重量份。The addition amount of the adhesion improving agent in the curable composition of the present invention is preferably 0.1 to 20 parts by weight with respect to 100 parts by weight of the main component.

<1-4-3.防凝聚劑> 就與溶劑相溶以防止凝聚的觀點而言,本發明的硬化性組成物也可還含有防凝聚劑。防凝聚劑是為了與溶劑相溶以防止凝聚而使用。本發明的硬化性組成物中所任意添加的防凝聚劑的具體例為迪斯帕畢克(DISPERBYK)-145、迪斯帕畢克(DISPERBYK)-161、迪斯帕畢克(DISPERBYK)-162、迪斯帕畢克(DISPERBYK)-163、迪斯帕畢克(DISPERBYK)-164、迪斯帕畢克(DISPERBYK)-182、迪斯帕畢克(DISPERBYK)-184、迪斯帕畢克(DISPERBYK)-185、迪斯帕畢克(DISPERBYK)-2163、迪斯帕畢克(DISPERBYK)-2164、BYK-220S、迪斯帕畢克(DISPERBYK)-191、迪斯帕畢克(DISPERBYK)-199、迪斯帕畢克(DISPERBYK)-2015(均為商品名,日本畢克化學(BYK Chemie Japan)股份有限公司)、FTX-218、福吉特(Ftergent)710FM、福吉特(Ftergent)710FS(均為商品名,尼奧斯(Neos)股份有限公司)、弗洛倫(Flowlen)G-600及弗洛倫(Flowlen)G-700(均為商品名,共榮社化學股份有限公司)。可使用這些防凝聚劑中的一種以上。<1-4-3. Anti-agglomerating agent> From the viewpoint of being compatible with a solvent to prevent aggregation, the curable composition of the present invention may further contain an anti-agglomeration agent. The anti-agglomeration agent is used to be compatible with the solvent to prevent aggregation. Specific examples of the anti-agglomerating agent arbitrarily added to the hardenable composition of the present invention are DISPERBYK-145, DISPERBYK-161, DISPERBYK- 162, DISPERBYK -163, DISPERBYK -164, DISPERBYK -182, DISPERBYK -184, DISPERBYK DISPERBYK-185, DISPERBYK-2163, DISPERBYK-2164, BYK-220S, DISPERBYK-191, DISPERBYK (191 DISPERBYK)-199, DISPERBYK-2015 (all trade names, BYK Chemie Japan Co., Ltd.), FTX-218, Ftergent 710FM, Ftergent ) 710FS (both trade names, Neos Co., Ltd.), Floren (Flowlen) G-600 and Floren (Flowlen) G-700 (both trade names, Kyoeisha Chemical Co., Ltd. the company). One or more of these anti-agglomerating agents can be used.

<1-4-4.抗氧化劑> 就防止硬化膜暴露於高溫下時的黃變的觀點而言,本發明的硬化性組成物也可還含有抗氧化劑。抗氧化劑的具體例為易璐佳諾斯(Irganox)1010、易璐佳諾斯(Irganox)1010FF、易璐佳諾斯(Irganox)1035、易璐佳諾斯(Irganox)1035FF、易璐佳諾斯(Irganox)1076、易璐佳諾斯(Irganox)1076FD、易璐佳諾斯(Irganox)1098、易璐佳諾斯(Irganox)1135、易璐佳諾斯(Irganox)1330、易璐佳諾斯(Irganox)1726、易璐佳諾斯(Irganox)1425WL、易璐佳諾斯(Irganox)1520L、易璐佳諾斯(Irganox)245、易璐佳諾斯(Irganox)245FF、易璐佳諾斯(Irganox)259、易璐佳諾斯(Irganox)3114、易璐佳諾斯(Irganox)565、易璐佳諾斯(Irganox)565DD(均為商品名,日本巴斯夫(BASF Japan)股份有限公司)、艾迪科斯塔波(ADK STAB)AO-20、艾迪科斯塔波(ADK STAB)AO-30、艾迪科斯塔波(ADK STAB)AO-50、艾迪科斯塔波(ADK STAB)AO-60及艾迪科斯塔波(ADK STAB)AO-80(均為商品名,艾迪科(ADEKA)股份有限公司)。可使用這些抗氧化劑中的一種以上。<1-4-4. Antioxidant> From the viewpoint of preventing yellowing of the cured film when exposed to high temperature, the curable composition of the present invention may further contain an antioxidant. Specific examples of antioxidants are Irganox 1010, Irganox 1010FF, Irganox 1035, Irganox 1035FF, Irganox (Irganox) 1076, Irganox 1076FD, Irganox 1098, Irganox 1135, Irganox 1135, Irganox 1330, Irganox (Irganox) 1726, Irganox 1425WL, Irganox 1520L, Irganox 245, Irganox 245FF, Irganox (Irganox) 259, Irganox 3114, Irganox 565, Irganox 565DD (all are trade names, BASF Japan) Co., Ltd. ), ADK STAB (ADK STAB) AO-20, ADK STAB (ADK STAB) AO-30, ADK STAB (ADK STAB) AO-50, ADK STAB (ADK STAB) AO-60 and ADK STAB AO-80 (both trade names, ADEKA Co., Ltd.). One or more of these antioxidants can be used.

這些抗氧化劑的具體例中,優選為易璐佳諾斯(Irganox)1010、艾迪科斯塔波(ADK STAB)AO-60。Specific examples of these antioxidants are preferably Irganox 1010 and ADK STAB AO-60.

相對於主要成分量100重量份,本發明的硬化性組成物中的抗氧化劑的添加量優選為0.01重量份~5重量份。The addition amount of the antioxidant in the curable composition of the present invention is preferably 0.01 to 5 parts by weight relative to 100 parts by weight of the main component.

<1-4-5.交聯劑> 就提高耐熱性、耐化學品性、膜面內均勻性、撓性、柔軟性、彈性的觀點而言,本發明的硬化性組成物也可還含有多官能環氧化合物(C)以外的環氧化合物、三聚氰胺化合物及雙疊氮化合物等交聯劑。<1-4-5. Crosslinking agent> From the viewpoint of improving heat resistance, chemical resistance, film surface uniformity, flexibility, flexibility, and elasticity, the curable composition of the present invention may further contain rings other than the polyfunctional epoxy compound (C) Oxygen compounds, melamine compounds and diazide compounds and other cross-linking agents.

多官能環氧化合物(C)以外的環氧化合物的例子為雙酚A型環氧化合物、雙酚F型環氧化合物、聯苯型二官能環氧化合物及具有矽氧烷鍵結部位的二官能環氧化合物等具有兩個縮水甘油醚基的化合物;對苯二甲酸二縮水甘油酯、鄰苯二甲酸二縮水甘油酯及1,2-環己烷二羧酸二縮水甘油酯等具有兩個縮水甘油酯基的化合物;及3',4'-環氧環己基甲基-3,4-環氧環己烷羧酸酯等具有兩個脂環式環氧基的化合物。可使用這些化合物中的一種以上。Examples of epoxy compounds other than the multifunctional epoxy compound (C) are bisphenol A epoxy compounds, bisphenol F epoxy compounds, biphenyl difunctional epoxy compounds, and disiloxanes having a siloxane bond site. Compounds with two glycidyl ether groups such as functional epoxy compounds; diglycidyl terephthalate, diglycidyl phthalate and 1,2-cyclohexanedicarboxylic acid diglycidyl ester have two A glycidyl ester group; and 3',4'-epoxycyclohexylmethyl-3,4-epoxycyclohexane carboxylate and other compounds with two alicyclic epoxy groups. One or more of these compounds can be used.

雙酚A型環氧化合物的市售品的具體例為jER 828、jER 1004、jER 1009(均為商品名,三菱化學股份有限公司);雙酚F型環氧化合物的市售品的具體例為jER 806、jER 4005P(均為商品名,三菱化學股份有限公司);聯苯型二官能環氧化合物的市售品的具體例為jER YX4000、jER YX4000H、jER YL6121H(均為商品名,三菱化學股份有限公司);具有矽氧烷鍵結部位的二官能環氧化合物的市售品的具體例為TSL9906(商品名,日本邁圖高新材料(Momentive Performance Materials Japan)有限責任公司);對苯二甲酸二縮水甘油酯的市售品的具體例為丹納考爾(Denacol)EX-711(商品名,長瀨化成(Nagase chemteX)股份有限公司);鄰苯二甲酸二縮水甘油酯的市售品的具體例為丹納考爾(Denacol)EX-721(商品名,長瀨化成(Nagase chemteX)股份有限公司);3',4'-環氧環己基甲基-3,4-環氧環己烷羧酸酯的市售品的具體例為賽羅西德(Celloxide)2021P(商品名,大賽璐(Daicel)股份有限公司)。Specific examples of commercially available products of bisphenol A-type epoxy compounds are jER 828, jER 1004, and jER 1009 (all trade names, Mitsubishi Chemical Corporation); specific examples of commercially available products of bisphenol F-type epoxy compounds JER 806, jER 4005P (both trade names, Mitsubishi Chemical Corporation); specific examples of commercially available products of biphenyl type bifunctional epoxy compounds are jER YX4000, jER YX4000H, jER YL6121H (both trade names, Mitsubishi) Chemical Co., Ltd.); a specific example of a commercially available product of a difunctional epoxy compound having a siloxane bond site is TSL9906 (trade name, Momentive Performance Materials Japan Co., Ltd.); p-benzene Specific examples of commercially available products of diglycidyl dicarboxylate are Denacol EX-711 (trade name, Nagase chemteX Co., Ltd.); the market of diglycidyl phthalate Specific examples of products sold are Denacol EX-721 (trade name, Nagase chemteX Co., Ltd.); 3',4'-epoxycyclohexylmethyl-3,4-cyclo A specific example of a commercially available product of oxycyclohexane carboxylic acid ester is Celloxide 2021P (trade name, Daicel Co., Ltd.).

相對於主要成分量100重量份,本發明的硬化性組成物中的多官能環氧化合物(C)以外的環氧化合物的添加量優選為1重量份~20重量份。The addition amount of the epoxy compound other than the polyfunctional epoxy compound (C) in the curable composition of the present invention is preferably 1 to 20 parts by weight relative to 100 parts by weight of the main component.

<1-4-6.光酸產生劑> 就可利用曝光及顯影來進行圖案化的觀點而言,本發明的硬化性組成物也可還含有光酸產生劑。光酸產生劑的例子為1,2-醌二疊氮化合物。<1-4-6. Photoacid generator> From the viewpoint of patterning by exposure and development, the curable composition of the present invention may further contain a photoacid generator. Examples of photoacid generators are 1,2-quinonediazide compounds.

1,2-醌二疊氮化合物的具體例為2,3,4-三羥基二苯甲酮-1,2-萘醌二疊氮-4-磺酸酯、2,3,4-三羥基二苯甲酮-1,2-萘醌二疊氮-5-磺酸酯(例如,商品名,NT-200,東洋合成化學工業)、2,4,6-三羥基二苯甲酮-1,2-萘醌二疊氮-4-磺酸酯、2,4,6-三羥基二苯甲酮-1,2-萘醌二疊氮-5-磺酸酯;2,2',4,4'-四羥基二苯甲酮-1,2-萘醌二疊氮-4-磺酸酯、2,2',4,4'-四羥基二苯甲酮-1,2-萘醌二疊氮-5-磺酸酯、2,3,3',4-四羥基二苯甲酮-1,2-萘醌二疊氮-4-磺酸酯、2,3,3',4-四羥基二苯甲酮-1,2-萘醌二疊氮-5-磺酸酯、2,3,4,4'-四羥基二苯甲酮-1,2-萘醌二疊氮-4-磺酸酯、2,3,4,4'-四羥基二苯甲酮-1,2-萘醌二疊氮-5-磺酸酯;雙(2,4-二羥基苯基)甲烷-1,2-萘醌二疊氮-4-磺酸酯、雙(2,4-二羥基苯基)甲烷-1,2-萘醌二疊氮-5-磺酸酯、雙(對羥基苯基)甲烷-1,2-萘醌二疊氮-4-磺酸酯、雙(對羥基苯基)甲烷-1,2-萘醌二疊氮-5-磺酸酯;三(對羥基苯基)甲烷-1,2-萘醌二疊氮-4-磺酸酯、三(對羥基苯基)甲烷-1,2-萘醌二疊氮-5-磺酸酯、1,1,1-三(對羥基苯基)乙烷-1,2-萘醌二疊氮-4-磺酸酯、1,1,1-三(對羥基苯基)乙烷-1,2-萘醌二疊氮-5-磺酸酯;雙(2,3,4-三羥基苯基)甲烷-1,2-萘醌二疊氮-4-磺酸酯、雙(2,3,4-三羥基苯基)甲烷-1,2-萘醌二疊氮-5-磺酸酯、2,2-雙(2,3,4-三羥基苯基)丙烷-1,2-萘醌二疊氮-4-磺酸酯、2,2-雙(2,3,4-三羥基苯基)丙烷-1,2-萘醌二疊氮-5-磺酸酯;1,1,3-三(2,5-二甲基-4-羥基苯基)-3-苯基丙烷-1,2-萘醌二疊氮-4-磺酸酯、1,1,3-三(2,5-二甲基-4-羥基苯基)-3-苯基丙烷-1,2-萘醌二疊氮-5-磺酸酯、4,4'-[1-[4-[1-[4-羥基苯基]-1-甲基乙基]苯基]亞乙基]雙酚-1,2-萘醌二疊氮-4-磺酸酯、4,4'-[1-[4-[1-[4-羥基苯基]-1-甲基乙基]苯基]亞乙基]雙酚-1,2-萘醌二疊氮-5-磺酸酯;雙(2,5-二甲基-4-羥基苯基)-2-羥基苯基甲烷-1,2-萘醌二疊氮-4-磺酸酯、雙(2,5-二甲基-4-羥基苯基)-2-羥基苯基甲烷-1,2-萘醌二疊氮-5-磺酸酯、3,3,3',3'-四甲基-1,1'-螺二茚-5,6,7,5',6',7'-己醇-1,2-萘醌二疊氮-4-磺酸酯、3,3,3',3'-四甲基-1,1'-螺二茚-5,6,7,5',6',7'-己醇-1,2-萘醌二疊氮-5-磺酸酯;2,2,4-三甲基-7,2',4'-三羥基黃烷-1,2-萘醌二疊氮-4-磺酸酯及2,2,4-三甲基-7,2',4'-三羥基黃烷-1,2-萘醌二疊氮-5-磺酸酯。可使用這些光酸產生劑中的一種以上。Specific examples of 1,2-quinonediazide compounds are 2,3,4-trihydroxybenzophenone-1,2-naphthoquinonediazide-4-sulfonate and 2,3,4-trihydroxy Benzophenone-1,2-naphthoquinonediazide-5-sulfonate (for example, trade name, NT-200, Toyo Synthetic Chemical Industry), 2,4,6-trihydroxybenzophenone-1 ,2-naphthoquinonediazide-4-sulfonate, 2,4,6-trihydroxybenzophenone-1,2-naphthoquinonediazide-5-sulfonate; 2,2',4 ,4'-tetrahydroxybenzophenone-1,2-naphthoquinonediazide-4-sulfonate, 2,2',4,4'-tetrahydroxybenzophenone-1,2-naphthoquinone Diazide-5-sulfonate, 2,3,3',4-tetrahydroxybenzophenone-1,2-naphthoquinonediazide-4-sulfonate, 2,3,3',4 -Tetrahydroxybenzophenone-1,2-naphthoquinonediazide-5-sulfonate, 2,3,4,4'-tetrahydroxybenzophenone-1,2-naphthoquinonediazide- 4-sulfonate, 2,3,4,4'-tetrahydroxybenzophenone-1,2-naphthoquinonediazide-5-sulfonate; bis(2,4-dihydroxyphenyl)methane -1,2-naphthoquinonediazide-4-sulfonate, bis(2,4-dihydroxyphenyl)methane-1,2-naphthoquinonediazide-5-sulfonate, bis(p-hydroxy Phenyl)methane-1,2-naphthoquinonediazide-4-sulfonate, bis(p-hydroxyphenyl)methane-1,2-naphthoquinonediazide-5-sulfonate; tri(p-hydroxy Phenyl)methane-1,2-naphthoquinonediazide-4-sulfonate, tris(p-hydroxyphenyl)methane-1,2-naphthoquinonediazide-5-sulfonate, 1,1, 1-Tris(p-hydroxyphenyl)ethane-1,2-naphthoquinonediazide-4-sulfonate, 1,1,1-tris(p-hydroxyphenyl)ethane-1,2-naphthoquinone Diazide-5-sulfonate; bis(2,3,4-trihydroxyphenyl)methane-1,2-naphthoquinonediazide-4-sulfonate, bis(2,3,4-tris Hydroxyphenyl)methane-1,2-naphthoquinonediazide-5-sulfonate, 2,2-bis(2,3,4-trihydroxyphenyl)propane-1,2-naphthoquinonediazide -4-sulfonate, 2,2-bis(2,3,4-trihydroxyphenyl)propane-1,2-naphthoquinonediazide-5-sulfonate; 1,1,3-tri( 2,5-dimethyl-4-hydroxyphenyl)-3-phenylpropane-1,2-naphthoquinonediazide-4-sulfonate, 1,1,3-tris(2,5-di Methyl-4-hydroxyphenyl)-3-phenylpropane-1,2-naphthoquinonediazide-5-sulfonate, 4,4'-[1-[4-[1-[4-hydroxyl Phenyl]-1-methylethyl]phenyl]ethylene]bisphenol-1,2-naphthoquinonediazide-4-sulfonate, 4,4'-[1-[4-[1 -[4-Hydroxyphenyl]-1-methylethyl]phenyl]ethylene]bisphenol-1,2-naphthoquinonediazide-5-sulfonate; bis(2,5-dimethyl Yl-4-hydroxyphenyl)-2-hydroxyphenylmethane-1,2-naphthoquinonediazide-4-sulfonate, bis(2,5-dimethyl-4-hydroxybenzene Yl)-2-hydroxyphenylmethane-1,2-naphthoquinonediazide-5-sulfonate, 3,3,3',3'-tetramethyl-1,1'-spirobiindene-5 ,6,7,5',6',7'-hexanol-1,2-naphthoquinonediazide-4-sulfonate, 3,3,3',3'-tetramethyl-1,1 '-Spirobiindene-5,6,7,5',6',7'-hexanol-1,2-naphthoquinonediazide-5-sulfonate; 2,2,4-trimethyl- 7,2',4'-trihydroxyflavan-1,2-naphthoquinonediazide-4-sulfonate and 2,2,4-trimethyl-7,2',4'-trihydroxy yellow Alkane-1,2-naphthoquinonediazide-5-sulfonate. One or more of these photoacid generators can be used.

相對於主要成分量100重量份,本發明的硬化性組成物中的光酸產生劑的添加量優選為1重量份~20重量份。The addition amount of the photoacid generator in the curable composition of the present invention is preferably 1 part by weight to 20 parts by weight relative to 100 parts by weight of the main component.

<1-4-7.多官能(甲基)丙烯酸酯化合物> 就提高耐劃傷性的觀點而言,本發明的硬化性組成物也可還含有多官能(甲基)丙烯酸酯化合物。<1-4-7. Multifunctional (meth)acrylate compound> From the viewpoint of improving scratch resistance, the curable composition of the present invention may further contain a polyfunctional (meth)acrylate compound.

多官能(甲基)丙烯酸酯化合物的例子為每一分子具有兩個(甲基)丙烯醯基的化合物及每一分子具有三個以上的(甲基)丙烯醯基的化合物。Examples of polyfunctional (meth)acrylate compounds are compounds having two (meth)acryloyl groups per molecule and compounds having three or more (meth)acryloyl groups per molecule.

每一分子具有兩個(甲基)丙烯醯基的化合物的具體例為乙二醇二(甲基)丙烯酸酯、1,4-丁二醇二(甲基)丙烯酸酯、1,3-丁二醇二(甲基)丙烯酸酯、新戊二醇二(甲基)丙烯酸酯、1,6-己二醇二(甲基)丙烯酸酯、二乙二醇二(甲基)丙烯酸酯、三乙二醇二(甲基)丙烯酸酯、四乙二醇二(甲基)丙烯酸酯、聚乙二醇二(甲基)丙烯酸酯、丙二醇二(甲基)丙烯酸酯、二丙二醇二(甲基)丙烯酸酯、三丙二醇二(甲基)丙烯酸酯、四丙二醇二(甲基)丙烯酸酯、聚丙二醇二(甲基)丙烯酸酯、環氧乙烷改性雙酚A二(甲基)丙烯酸酯、環氧乙烷改性雙酚F二(甲基)丙烯酸酯及環氧乙烷改性雙酚S二(甲基)丙烯酸酯等二醇化合物的二(甲基)丙烯酸酯體; 甘油丙烯酸酯甲基丙烯酸酯、甘油二(甲基)丙烯酸酯及乙氧基化異氰脲酸二丙烯酸酯等三醇化合物的二(甲基)丙烯酸酯體; 雙酚A二(甲基)丙烯酸酯、雙酚F二(甲基)丙烯酸酯及雙酚S二(甲基)丙烯酸酯等雙酚化合物的二(甲基)丙烯酸酯體;及 表氯醇改性乙二醇二(甲基)丙烯酸酯、表氯醇改性1,6-己二醇二(甲基)丙烯酸酯、表氯醇改性二乙二醇二(甲基)丙烯酸酯、表氯醇改性三乙二醇二(甲基)丙烯酸酯、表氯醇改性四乙二醇二(甲基)丙烯酸酯、表氯醇改性聚乙二醇二(甲基)丙烯酸酯、表氯醇改性丙二醇二(甲基)丙烯酸酯、表氯醇改性二丙二醇二(甲基)丙烯酸酯、表氯醇改性三丙二醇二(甲基)丙烯酸酯、表氯醇改性四丙二醇二(甲基)丙烯酸酯、表氯醇改性聚丙二醇二(甲基)丙烯酸酯、雙酚A型環氧化合物的(甲基)丙烯酸加成物、雙酚F型環氧化合物的(甲基)丙烯酸加成物及雙酚S型環氧化合物的(甲基)丙烯酸加成物等二環氧化合物的(甲基)丙烯酸加成物。可使用這些化合物中的一種以上。Specific examples of compounds having two (meth)acryloyl groups per molecule are ethylene glycol di(meth)acrylate, 1,4-butanediol di(meth)acrylate, 1,3-butane Glycol di(meth)acrylate, neopentyl glycol di(meth)acrylate, 1,6-hexanediol di(meth)acrylate, diethylene glycol di(meth)acrylate, tri Ethylene glycol di(meth)acrylate, tetraethylene glycol di(meth)acrylate, polyethylene glycol di(meth)acrylate, propylene glycol di(meth)acrylate, dipropylene glycol di(meth)acrylate ) Acrylate, tripropylene glycol di(meth)acrylate, tetrapropylene glycol di(meth)acrylate, polypropylene glycol di(meth)acrylate, ethylene oxide modified bisphenol A di(meth)acrylate 2. Di(meth)acrylates of glycol compounds such as ethylene oxide modified bisphenol F di(meth)acrylate and ethylene oxide modified bisphenol S di(meth)acrylate; Di(meth)acrylate body of triol compounds such as glycerin acrylate methacrylate, glycerin di(meth)acrylate and ethoxylated isocyanurate diacrylate; Di(meth)acrylate bodies of bisphenol compounds such as bisphenol A di(meth)acrylate, bisphenol F di(meth)acrylate and bisphenol S di(meth)acrylate; and Epichlorohydrin modified ethylene glycol di(meth)acrylate, epichlorohydrin modified 1,6-hexanediol di(meth)acrylate, epichlorohydrin modified diethylene glycol di(meth) Acrylate, epichlorohydrin modified triethylene glycol di(meth)acrylate, epichlorohydrin modified tetraethylene glycol di(meth)acrylate, epichlorohydrin modified polyethylene glycol di(meth) ) Acrylate, epichlorohydrin modified propylene glycol di(meth)acrylate, epichlorohydrin modified dipropylene glycol di(meth)acrylate, epichlorohydrin modified tripropylene glycol di(meth)acrylate, epichlorohydrin Alcohol-modified tetrapropylene glycol di(meth)acrylate, epichlorohydrin modified polypropylene glycol di(meth)acrylate, (meth)acrylic adduct of bisphenol A epoxy compound, bisphenol F ring (Meth)acrylic acid adducts of oxygen compounds (meth)acrylic acid adducts and (meth)acrylic acid adducts of bisphenol S-type epoxy compounds. One or more of these compounds can be used.

每一分子具有三個以上的(甲基)丙烯醯基的化合物的具體例為三羥甲基丙烷三(甲基)丙烯酸酯、三羥甲基丙烷環氧乙烷(Ethylene Oxide,EO)改性三(甲基)丙烯酸酯、三羥甲基丙烷環氧丙烷(Propylene Oxide,PO)改性三(甲基)丙烯酸酯、甘油三(甲基)丙烯酸酯、甘油EO改性三(甲基)丙烯酸酯、甘油PO改性三(甲基)丙烯酸酯、季戊四醇三(甲基)丙烯酸酯、乙氧基化異氰脲酸三(甲基)丙烯酸酯及e-己內酯改性三-(2-(甲基)丙烯醯氧基乙基)異氰脲酸酯等三官能(甲基)丙烯酸酯化合物; 二-三羥甲基丙烷四(甲基)丙烯酸酯、乙氧基化季戊四醇四(甲基)丙烯酸酯、季戊四醇四(甲基)丙烯酸酯、季戊四醇烷氧基四(甲基)丙烯酸酯及二甘油EO改性四丙烯酸酯等四官能(甲基)丙烯酸酯化合物; 二季戊四醇五(甲基)丙烯酸酯等五官能(甲基)丙烯酸酯化合物; 二季戊四醇六丙烯酸酯等六官能(甲基)丙烯酸酯化合物;及 具有羧基的多官能(甲基)丙烯酸酯化合物。可使用這些化合物中的一種以上。Specific examples of compounds having three or more (meth)acryloyl groups per molecule are trimethylolpropane tri(meth)acrylate, trimethylolpropane ethylene oxide (EO) Tri(meth)acrylate, trimethylolpropane propylene oxide (Propylene Oxide, PO) modified tri(meth)acrylate, glycerin tri(meth)acrylate, glycerin EO modified tri(methyl) ) Acrylate, glycerol PO modified tri(meth)acrylate, pentaerythritol tri(meth)acrylate, ethoxylated isocyanurate tri(meth)acrylate and e-caprolactone modified tri- (2-(meth)acryloyloxyethyl) isocyanurate and other trifunctional (meth)acrylate compounds; Di-trimethylolpropane tetra (meth) acrylate, ethoxylated pentaerythritol tetra (meth) acrylate, pentaerythritol tetra (meth) acrylate, pentaerythritol alkoxy tetra (meth) acrylate and di Glycerol EO modified tetrafunctional (meth)acrylate compounds such as tetraacrylate; Pentaerythritol penta(meth)acrylate and other pentafunctional (meth)acrylate compounds; Hexafunctional (meth)acrylate compounds such as dipentaerythritol hexaacrylate; and Multifunctional (meth)acrylate compound with carboxyl groups. One or more of these compounds can be used.

作為三官能丙烯酸酯化合物的、三羥甲基丙烷三丙烯酸酯的市售品的具體例為NK酯(NK ESTER)TMPT(商品名,新中村化學工業股份有限公司)、TMPTA(商品名,大賽璐奧諾斯(Daicel Allnex)股份有限公司)及亞羅尼斯(Aronix)M-309(商品名,東亞合成股份有限公司); 三羥甲基丙烷EO改性三丙烯酸酯的市售品的具體例為TMPEOTA(商品名,大賽璐奧諾斯(Daicel Allnex)股份有限公司)、亞羅尼斯(Aronix)M-350、亞羅尼斯(Aronix)M-360(均為商品名,東亞合成股份有限公司); 三羥甲基丙烷PO改性三丙烯酸酯的市售品的具體例為艾柏西路(EBECRYL)135(商品名,大賽璐奧諾斯(Daicel Allnex)股份有限公司)、亞羅尼斯(Aronix)M-310、亞羅尼斯(Aronix)M-321(均為商品名,東亞合成股份有限公司); 甘油PO改性三丙烯酸酯的市售品的具體例為OTA 480(商品名,大賽璐奧諾斯(Daicel Allnex)股份有限公司); 乙氧基化異氰脲酸三丙烯酸酯的市售品的具體例為NK酯(NK ESTER)A-9300(商品名,新中村化學工業股份有限公司); e-己內酯改性三-(2-丙烯醯氧基乙基)異氰脲酸酯的市售品的具體例為NK酯(NK ESTER)A-9300-1CL(商品名,新中村化學工業股份有限公司)。Specific examples of commercially available products of trimethylolpropane triacrylate as trifunctional acrylate compounds are NK ester (NK ESTER) TMPT (trade name, Shin Nakamura Chemical Industry Co., Ltd.), TMPTA (trade name, contest Luonuosi (Daicel Allnex) Co., Ltd. and Aronix (Aronix) M-309 (trade name, East Asia Synthetic Co., Ltd.); Specific examples of commercially available products of trimethylolpropane EO modified triacrylate are TMPEOTA (trade name, Daicel Allnex Co., Ltd.), Aronix M-350, Yarrow Nice (Aronix) M-360 (both trade names, East Asia Synthetic Co., Ltd.); Specific examples of commercially available products of trimethylolpropane PO modified triacrylate are EBECRYL 135 (trade name, Daicel Allnex Co., Ltd.), Aronix (Aronix) ) M-310, Aronix M-321 (both trade names, East Asia Synthetic Co., Ltd.); A specific example of a commercially available product of glycerin PO modified triacrylate is OTA 480 (trade name, Daicel Allnex Co., Ltd.); A specific example of a commercially available product of ethoxylated isocyanurate triacrylate is NK ester (NK ESTER) A-9300 (trade name, Shin Nakamura Chemical Industry Co., Ltd.); A specific example of a commercially available product of e-caprolactone modified tri-(2-acryloyloxyethyl) isocyanurate is NK ester (NK ESTER) A-9300-1CL (trade name, Shin Nakamura Chemical Industrial Co., Ltd.).

作為三官能甲基丙烯酸酯化合物的三羥甲基丙烷三甲基丙烯酸酯的市售品的具體例為NK酯(NK ESTER)TMPT(商品名,新中村化學工業股份有限公司)。A specific example of a commercially available product of trimethylolpropane trimethacrylate as a trifunctional methacrylate compound is NK ester (NK ESTER) TMPT (trade name, Shin Nakamura Chemical Industry Co., Ltd.).

作為四官能丙烯酸酯化合物的、二-三羥甲基丙烷四丙烯酸酯的市售品的具體例為NK酯(NK ESTER)AD-TMP(商品名,新中村化學工業股份有限公司)、艾柏西路(EBECRYL)140及艾柏西路(EBECRYL)1142(均為商品名,大賽璐奧諾斯(Daicel Allnex)股份有限公司)、亞羅尼斯(Aronix)M-408(商品名,東亞合成股份有限公司); 乙氧基化季戊四醇四丙烯酸酯的市售品的具體例為NK酯(NK ESTER)ATM-35E(商品名,新中村化學工業股份有限公司); 季戊四醇四丙烯酸酯的市售品的具體例為NK酯(NK ESTER)A-TMMT(商品名,新中村化學工業股份有限公司); 季戊四醇烷氧基四丙烯酸酯的市售品的具體例為艾柏西路(EBECRYL)40(商品名,大賽璐奧諾斯(Daicel Allnex)股份有限公司); 二甘油EO改性四丙烯酸酯的市售品的具體例為亞羅尼斯(Aronix)M-460(商品名,東亞合成股份有限公司)。Specific examples of commercially available products of di-trimethylolpropane tetraacrylate as tetrafunctional acrylate compounds are NK ester (NK ESTER) AD-TMP (trade name, Shin Nakamura Chemical Industry Co., Ltd.), Aibo EBECRYL 140 and EBECRYL 1142 (both trade names, Daicel Allnex Co., Ltd.), Aronix M-408 (trade name, East Asia Synthesizer) Co., Ltd.); A specific example of a commercially available product of ethoxylated pentaerythritol tetraacrylate is NK ester (NK ESTER) ATM-35E (trade name, Shin Nakamura Chemical Industry Co., Ltd.); A specific example of a commercially available product of pentaerythritol tetraacrylate is NK ester (NK ESTER) A-TMMT (trade name, Shin Nakamura Chemical Industry Co., Ltd.); A specific example of a commercially available product of pentaerythritol alkoxytetraacrylate is EBECRYL 40 (trade name, Daicel Allnex Co., Ltd.); A specific example of a commercially available product of diglycerin EO modified tetraacrylate is Aronix M-460 (trade name, East Asia Synthetic Co., Ltd.).

作為六官能丙烯酸酯化合物的二季戊四醇六丙烯酸酯的市售品的具體例為NK酯(NK ESTER)A-DPH(商品名,新中村化學工業股份有限公司)及DPHA(商品名,大賽璐奧諾斯(Daicel Allnex)股份有限公司)。Specific examples of commercially available products of dipentaerythritol hexaacrylate as hexafunctional acrylate compounds are NK ester (NK ESTER) A-DPH (trade name, Shin Nakamura Chemical Industry Co., Ltd.) and DPHA (trade name, Daicel) Daicel Allnex Co., Ltd.).

具有羧基的多官能丙烯酸酯化合物的市售品的具體例為亞羅尼斯(Aronix)M-510及亞羅尼斯(Aronix)M-520(均為商品名,東亞合成股份有限公司)。Specific examples of commercially available products of polyfunctional acrylate compounds having a carboxyl group are Aronix M-510 and Aronix M-520 (both trade names, East Asia Synthetic Co., Ltd.).

作為三官能丙烯酸酯化合物的乙氧基化異氰脲酸三丙烯酸酯及作為二官能丙烯酸酯化合物的乙氧基化異氰脲酸二丙烯酸酯的混合物的市售品的具體例為亞羅尼斯(Aronix)M-315(3重量%~13重量%)(商品名,東亞合成股份有限公司,括弧內的含有率為混合物中的乙氧基化異氰脲酸二丙烯酸酯的含有率的目錄記載值)。A specific example of a commercially available product of a mixture of ethoxylated isocyanurate triacrylate as a trifunctional acrylate compound and ethoxylated isocyanurate diacrylate as a difunctional acrylate compound is Aronis. (Aronix) M-315 (3% to 13% by weight) (trade name, East Asia Synthetic Co., Ltd., content list in parentheses is the content rate of ethoxylated isocyanurate diacrylate in the mixture Record the value).

作為三官能丙烯酸酯化合物的季戊四醇三丙烯酸酯及作為四官能丙烯酸酯化合物的季戊四醇四丙烯酸酯的混合物的市售品的具體例為PETIA、PETRA及PETA(均為商品名,大賽璐奧諾斯(Daicel Allnex)股份有限公司)、亞羅尼斯(Aronix)M-306(65重量%~70重量%)、亞羅尼斯(Aronix)M-305(55重量%~63重量%)及亞羅尼斯(Aronix)M-450(未滿10重量%)(均為商品名;東亞合成股份有限公司,括弧內的含有率為混合物中的季戊四醇三丙烯酸酯的含有率的目錄記載值)。Specific examples of commercially available products of a mixture of pentaerythritol triacrylate as a trifunctional acrylate compound and pentaerythritol tetraacrylate as a tetrafunctional acrylate compound are PETIA, PETRA, and PETA (all are trade names, Daicel Onos ( Daicel Allnex Co., Ltd.), Aronix M-306 (65% to 70% by weight), Aronix M-305 (55% to 63% by weight) and Aronix ( Aronix) M-450 (less than 10% by weight) (all are trade names; East Asia Synthetic Co., Ltd., the content rate in parentheses is listed in the catalogue of the content rate of pentaerythritol triacrylate in the mixture).

作為五官能丙烯酸酯的二季戊四醇五丙烯酸酯及作為六官能丙烯酸酯的二季戊四醇六丙烯酸酯的混合物的市售品的具體例為亞羅尼斯(Aronix)M-403(50重量%~60重量%)、亞羅尼斯(Aronix)M-400(40重量%~50重量%)、亞羅尼斯(Aronix)M-402(30重量%~40重量%)、亞羅尼斯(Aronix)M-404(30重量%~40重量%)、亞羅尼斯(Aronix)M-406(25重量%~35重量%)及亞羅尼斯(Aronix)M-405(10重量%~20重量%)(商品名,東亞合成股份有限公司,括弧內的含有率為混合物中的季戊四醇五丙烯酸酯的含有率的目錄記載值)。A specific example of a commercially available product of a mixture of dipentaerythritol pentaacrylate as a pentafunctional acrylate and dipentaerythritol hexaacrylate as a hexafunctional acrylate is Aronix M-403 (50% by weight to 60% by weight) ), Aronix M-400 (40% by weight to 50% by weight), Aronix M-402 (30% by weight to 40% by weight), Aronix M-404 ( 30% by weight to 40% by weight), Aronix M-406 (25% by weight to 35% by weight) and Aronix M-405 (10% by weight to 20% by weight) (trade name, East Asia Synthetic Co., Ltd., the content rate in parentheses is the cataloged value of the content rate of pentaerythritol pentaacrylate in the mixture).

相對於主要成分量100重量份,本發明的硬化性組成物中的多官能(甲基)丙烯酸酯化合物的添加量優選為1重量份~20重量份。The addition amount of the polyfunctional (meth)acrylate compound in the curable composition of the present invention is preferably 1 to 20 parts by weight relative to 100 parts by weight of the main component.

<1-4-8.光聚合起始劑> 就提高低溫硬化性的觀點而言,本發明的硬化性組成物也可還含有光聚合起始劑。在添加光聚合起始劑的情況下,可通過與多官能(甲基)丙烯酸酯化合物並用並進行紫外線照射步驟來降低煆燒溫度。<1-4-8. Photopolymerization initiator> From the viewpoint of improving low-temperature curability, the curable composition of the present invention may further contain a photopolymerization initiator. In the case of adding a photopolymerization initiator, the sintering temperature can be reduced by using an ultraviolet irradiation step in combination with a polyfunctional (meth)acrylate compound.

光聚合起始劑的具體例為二苯甲酮、米氏酮、4,4'-雙(二乙基氨基)二苯甲酮、氧雜蒽酮、硫雜蒽酮、異丙基氧雜蒽酮、2,4-二乙基硫雜蒽酮、2-乙基蒽醌、苯乙酮、2-羥基-2-甲基苯丙酮、2-羥基-2-甲基-4'-異丙基苯丙酮、1-羥基環己基苯基酮、異丙基安息香醚、異丁基安息香醚、2,2-二乙氧基苯乙酮、2,2-二甲氧基-2-苯基苯乙酮、樟腦醌、苯並蒽酮、2-甲基-1-[4-(甲硫基)苯基]-2-嗎啉代丙烷-1-酮(例如,商品名,豔佳固(Irgacure)907,日本巴斯夫(BASF Japan)股份有限公司)、2-苄基-2-二甲基氨基-1-(4-嗎啉代苯基)-丁酮-1(例如,商品名,豔佳固(Irgacure)369,日本巴斯夫(BASF Japan)股份有限公司)、4-二甲基氨基苯甲酸乙酯、4-二甲基氨基苯甲酸異戊酯、4,4'-二(叔丁基過氧基羰基)二苯甲酮、3,4,4'-三(叔丁基過氧基羰基)二苯甲酮、1,2-辛二酮,1-[4-(苯硫基)苯基]-2-(O-苯甲醯基肟)(例如,商品名,豔佳固(Irgacure)OXE01,日本巴斯夫(BASF Japan)股份有限公司)、乙酮,1-[9-乙基-6-(2-甲基苯甲醯基)-9H-哢唑-3-基]-1-(O-乙醯基肟)(例如,商品名,豔佳固(Irgacure)OXE02,日本巴斯夫(BASF Japan)股份有限公司)、豔佳固(Irgacure)OXE03(商品名,日本巴斯夫(BASF Japan)股份有限公司)、1,2-丙二酮,1-[4-[4-(2-羥基乙氧基)苯硫基]苯基]-2-(O-乙醯基肟)(例如,商品名,艾迪科亞庫魯茲(Adeka Arkls)NCI-930,艾迪科(ADEKA)股份有限公司)、艾迪科亞庫魯茲(Adeka Arkls)NCI-831(商品名,艾迪科(ADEKA)股份有限公司)、艾迪科奧普托瑪(Adeka Optomer)N-1919(商品名,艾迪科(ADEKA)股份有限公司)、2,4,6-三甲基苯甲醯基二苯基氧化膦、2-(4'-甲氧基苯乙烯基)-4,6-雙(三氯甲基)-均三嗪、2-(3',4'-二甲氧基苯乙烯基)-4,6-雙(三氯甲基)-均三嗪、2-(2',4'-二甲氧基苯乙烯基)-4,6-雙(三氯甲基)-均三嗪、2-(2'-甲氧基苯乙烯基)-4,6-雙(三氯甲基)-均三嗪、2-(4'-戊氧基苯乙烯基)-4,6-雙(三氯甲基)-均三嗪、4-[對-N,N-二(乙氧基羰基甲基)]-2,6-二(三氯甲基)-均三嗪、1,3-雙(三氯甲基)-5-(2'-氯苯基)-均三嗪、1,3-雙(三氯甲基)-5-(4'-甲氧基苯基)-均三嗪、2-(對二甲基氨基苯乙烯基)苯並噁唑、2-(對二甲基氨基苯乙烯基)苯並噻唑、2-巰基苯並噻唑、3,3'-羰基雙(7-二乙基氨基香豆素)、2-(鄰氯苯基)-4,4',5,5'-四苯基-1,2'-聯咪唑、2,2'-雙(2-氯苯基)-4,4',5,5'-四(4-乙氧基羰基苯基)-1,2'-聯咪唑、2,2'-雙(2,4-二氯苯基)-4,4',5,5'-四苯基-1,2'-聯咪唑、2,2'-雙(2,4-二溴苯基)-4,4',5,5'-四苯基-1,2'-聯咪唑、2,2'-雙(2,4,6-三氯苯基)-4,4',5,5'-四苯基-1,2'-聯咪唑、3-(2-甲基-2-二甲基氨基丙醯基)哢唑、3,6-雙(2-甲基-2-嗎啉代丙醯基)-9-正十二烷基哢唑、1-羥基環己基苯基酮及雙(η5 -2,4-環戊二烯-1-基)-雙(2,6-二氟-3-(1H-吡咯-1-基)-苯基)鈦。可使用這些光聚合起始劑中的一種以上。Specific examples of the photopolymerization initiator are benzophenone, Michler's ketone, 4,4'-bis(diethylamino)benzophenone, xanthone, thioxanthone, isopropyl oxa Anthrone, 2,4-diethylthioxanthone, 2-ethylanthraquinone, acetophenone, 2-hydroxy-2-methylbenzeneacetone, 2-hydroxy-2-methyl-4'-iso Propyl phenylacetone, 1-hydroxycyclohexyl phenyl ketone, isopropyl benzoin ether, isobutyl benzoin ether, 2,2-diethoxyacetophenone, 2,2-dimethoxy-2-benzene Acetophenone, camphorquinone, benzanthrone, 2-methyl-1-[4-(methylthio)phenyl]-2-morpholinopropane-1-one (for example, trade name, Yanjia Irgacure 907, BASF Japan Co., Ltd., 2-benzyl-2-dimethylamino-1-(4-morpholinophenyl)-butanone-1 (for example, trade name , Irgacure 369, BASF Japan Co., Ltd., 4-dimethylaminobenzoic acid ethyl ester, 4-dimethylaminobenzoic acid isoamyl ester, 4,4'-bis( Tert-butylperoxycarbonyl)benzophenone, 3,4,4'-tris(tert-butylperoxycarbonyl)benzophenone, 1,2-octanedione, 1-(4-(benzene Thio)phenyl]-2-(O-benzyl oxime) (for example, trade name, Irgacure OXE01, BASF Japan Co., Ltd.), ethyl ketone, 1-[9 -Ethyl-6-(2-methylbenzyl)-9H-oxazol-3-yl]-1-(O-acetyl oxime) (for example, trade name, Irgacure OXE02 , BASF Japan Co., Ltd., Irgacure OXE03 (trade name, BASF Japan Co., Ltd.), 1,2-propanedione, 1-[4-[4- (2-Hydroxyethoxy)phenylthio]phenyl]-2-(O-acetyl oxime) (for example, trade name, Adeka Arkls) NCI-930, Addico (ADEKA) Co., Ltd., Adeka Arkls NCI-831 (trade name, ADEKA Co., Ltd.), Adeka Optomer N- 1919 (trade name, ADEKA Corporation), 2,4,6-trimethylbenzyl diphenylphosphine oxide, 2-(4'-methoxystyryl)-4 ,6-bis(trichloromethyl)-s-triazine, 2-(3',4'-dimethoxystyryl)-4,6-bis(trichloromethyl)-s-triazine, 2 -(2',4'-dimethoxystyryl)-4,6-bis(trichloromethyl)-s-triazine, 2-(2'-methoxystyryl)-4,6 -Bis(trichloromethyl)-s-triazine, 2-(4'-pentyloxystyryl )-4,6-bis(trichloromethyl)-s-triazine, 4-[p-N,N-bis(ethoxycarbonylmethyl)]-2,6-bis(trichloromethyl)- S-triazine, 1,3-bis(trichloromethyl)-5-(2'-chlorophenyl)-s-triazine, 1,3-bis(trichloromethyl)-5-(4'-methyl Oxyphenyl)-s-triazine, 2-(p-dimethylaminostyryl)benzoxazole, 2-(p-dimethylaminostyryl)benzothiazole, 2-mercaptobenzothiazole, 3,3'-carbonylbis(7-diethylaminocoumarin), 2-(o-chlorophenyl)-4,4',5,5'-tetraphenyl-1,2'-biimidazole, 2,2'-bis(2-chlorophenyl)-4,4',5,5'-tetra(4-ethoxycarbonylphenyl)-1,2'-biimidazole, 2,2'-bis (2,4-dichlorophenyl)-4,4',5,5'-tetraphenyl-1,2'-biimidazole, 2,2'-bis(2,4-dibromophenyl)- 4,4',5,5'-tetraphenyl-1,2'-biimidazole, 2,2'-bis(2,4,6-trichlorophenyl)-4,4',5,5'-Tetraphenyl-1,2'-biimidazole, 3-(2-methyl-2-dimethylaminopropionyl) oxazole, 3,6-bis(2-methyl-2-morpholino Propionyl)-9-n-dodecyl oxazole, 1-hydroxycyclohexyl phenyl ketone and bis(η 5 -2,4-cyclopentadien-1-yl)-bis(2,6-di Fluoro-3-(1H-pyrrol-1-yl)-phenyl) titanium. One or more of these photopolymerization initiators can be used.

這些光聚合起始劑的具體例中,若使用選自1,2-辛二酮,1-[4-(苯硫基)苯基]-2-(O-苯甲醯基肟)及1,2-丙二酮,1-[4-[4-(2-羥基乙氧基)苯硫基]苯基]-2-(O-乙醯基肟)中的一種以上,則可以更少的曝光量來表現出硬化性組成物的低溫硬化性的提高效果。相對於主要成分量100重量份,適於表現出所述效果的光聚合起始劑的添加量為0.1重量份~5重量份。Among the specific examples of these photopolymerization initiators, if selected from 1,2-octanedione, 1-[4-(phenylthio)phenyl]-2-(O-benzoyl oxime) and 1 ,2-propanedione,1-[4-[4-(2-hydroxyethoxy)phenylthio]phenyl]-2-(O-acetyl oxime) more than one, it can be less The amount of exposure shows the effect of improving the low temperature curability of the curable composition. The addition amount of the photopolymerization initiator suitable for expressing the effect is 0.1 to 5 parts by weight relative to 100 parts by weight of the main component.

<1-5.硬化性組成物中所任意添加的溶劑> 本發明的硬化性組成物中除聚合溶劑以外,也可添加溶劑。本發明的硬化性組成物中所任意添加的溶劑(以下記載為「稀釋用溶劑(E)」)優選為可溶解醯亞胺化合物(A)、多官能羧基化合物(B)及多官能環氧化合物(C)的溶劑。在硬化性組成物含有所述添加劑(D)的情況下,稀釋用溶劑(E)優選為可進一步溶解添加劑(D)的溶劑。<1-5. Solvent added arbitrarily in the curable composition> In addition to the polymerization solvent, a solvent may be added to the curable composition of the present invention. The solvent arbitrarily added to the curable composition of the present invention (hereinafter referred to as "dilution solvent (E)") is preferably a soluble imide compound (A), polyfunctional carboxyl compound (B), and polyfunctional epoxy Compound (C) solvent. When the hardening composition contains the additive (D), the solvent (E) for dilution is preferably a solvent that can further dissolve the additive (D).

所述稀釋用溶劑(E)的具體例與作為所述反應溶劑的具體例而記載的溶劑相同。可使用這些溶劑中的一種以上。The specific example of the dilution solvent (E) is the same as the solvent described as the specific example of the reaction solvent. One or more of these solvents can be used.

<1-6.硬化性組成物的保存> 本發明的硬化性組成物若在-30℃~25℃的範圍下遮光保存,則組成物的經時穩定性良好而優選。更優選為在-20℃~5℃下保存。<1-6. Preservation of the curable composition> When the curable composition of the present invention is stored in a light-shielded range in the range of -30°C to 25°C, the composition has good stability over time, which is preferable. More preferably, it is stored at -20°C to 5°C.

<2.由硬化性組成物獲得的硬化膜> 本發明的硬化性組成物可通過如下方式而獲得:將醯亞胺化合物(A)、多官能羧基化合物(B)及多官能環氧化合物(C)加以混合,根據目標特性,而進一步選擇性添加添加劑(D)及稀釋用溶劑(E),將這些化合物均勻地混合溶解。<2. Cured film obtained from curable composition> The curable composition of the present invention can be obtained by mixing an amide imine compound (A), a polyfunctional carboxyl compound (B) and a polyfunctional epoxy compound (C), and further selectivity according to the target characteristics Adding additives (D) and dilution solvents (E), these compounds are uniformly mixed and dissolved.

通過將以所述方式獲得的硬化性組成物塗布於基板表面,在硬化性組成物包含組成物用溶劑的情況下,進而通過加熱步驟及減壓步驟等而將組成物用溶劑去除,由此可形成塗膜。將硬化性組成物塗布於基板表面的方法的具體例為旋塗法、輥塗法、浸漬法及狹縫塗布法。利用加熱步驟來去除組成物用溶劑的具體例為利用加熱板及烘箱的預烘烤。預烘烤條件視各成分的種類及調配比例而不同,通常在70℃~150℃下,若為加熱板則為1分鐘~5分鐘,若為烘箱則為5分鐘~15分鐘。By applying the curable composition obtained in the above manner to the surface of the substrate, when the curable composition contains the solvent for the composition, the solvent for the composition is further removed through a heating step, a depressurization step, etc., thereby Coating film can be formed. Specific examples of the method of applying the curable composition to the surface of the substrate are spin coating, roll coating, dipping, and slit coating. A specific example of using the heating step to remove the solvent for the composition is pre-baking using a hot plate and an oven. The pre-baking conditions vary depending on the type of ingredients and the mixing ratio. Usually, the temperature is 70°C to 150°C, if it is a hot plate, it is 1 to 5 minutes, and if it is an oven, it is 5 to 15 minutes.

最後,為了使塗膜完全硬化,可通過進行加熱處理來獲得硬化膜,所述加熱處理是在100℃~250℃、優選為120℃~230℃下,若為加熱板則進行5分鐘~60分鐘,若為烘箱則進行20分鐘~90分鐘。Finally, in order to completely cure the coating film, a cured film can be obtained by performing heat treatment at 100°C to 250°C, preferably 120°C to 230°C, or 5 minutes to 60 if it is a hot plate Minutes, if it is an oven, it takes 20 minutes to 90 minutes.

在將作為添加劑(D)的多官能(甲基)丙烯酸酯化合物及光聚合起始劑添加於硬化性組成物中的情況下,除利用加熱處理的熱硬化以外,也可並用利用紫外線照射的光硬化。所述情況下,對加熱處理前的塗膜進行紫外線照射。所照射的紫外線的波長理想的是350 nm以上,原因在於不對形成硬化膜後的光二聚化反應造成影響。再者,所述光硬化中所使用的紫外線可為偏光紫外線,也可為非偏光紫外線。When the polyfunctional (meth)acrylate compound and the photopolymerization initiator as an additive (D) are added to the curable composition, in addition to heat curing by heat treatment, ultraviolet irradiation may be used in combination. Light hardening. In this case, the coating film before the heat treatment is irradiated with ultraviolet rays. The wavelength of the irradiated ultraviolet rays is preferably 350 nm or more, because it does not affect the photodimerization reaction after forming the hardened film. Furthermore, the ultraviolet rays used in the photo-hardening may be polarized ultraviolet rays or unpolarized ultraviolet rays.

以所述方式獲得的硬化膜進行由醯亞胺化合物(A)的烷氧基矽烷基的縮合引起的三維交聯以及由多官能羧基化合物(B)的羧基及多官能環氧化合物(C)的環氧基的反應引起的三維交聯。此外,關於醯亞胺化合物(A)的烷氧基矽烷基的縮合,多官能羧基化合物(B)的羧基作為提高縮合反應速度的催化劑而發揮作用。因此,所獲得的硬化膜的耐熱性高,且相對於後述的聚合性液晶組成物中的溶劑的耐性高。The cured film obtained in this way undergoes three-dimensional crosslinking caused by the condensation of the alkoxysilane group of the amide imide compound (A), and the carboxyl group of the multifunctional carboxyl compound (B) and the multifunctional epoxy compound (C) The three-dimensional crosslinking caused by the epoxy reaction. In addition, regarding the condensation of the alkoxysilyl group of the amide imine compound (A), the carboxyl group of the polyfunctional carboxyl compound (B) functions as a catalyst for increasing the rate of the condensation reaction. Therefore, the obtained cured film has high heat resistance and high resistance to the solvent in the polymerizable liquid crystal composition described later.

另外,所獲得的硬化膜中存在具有醯亞胺化合物(A)的聚合性雙鍵及醯亞胺結構的基。所述具有聚合性雙鍵及醯亞胺結構的基通過照射直線偏光紫外線(波長的例子為313 nm),在與直線偏光紫外線的偏光方向平行的方向上排列的雙鍵引起光二聚化反應,從而對硬化膜賦予液晶配向能力,因此所獲得的硬化膜具有光配向性。In addition, there is a group having a polymerizable double bond of an imide compound (A) and an imide structure in the obtained cured film. The group having a polymerizable double bond and an imidate structure is irradiated with linearly polarized ultraviolet light (wavelength example is 313 nm), and double bonds arranged in a direction parallel to the polarization direction of the linearly polarized ultraviolet light cause a photodimerization reaction, Thus, the liquid crystal alignment ability is given to the cured film, and thus the obtained cured film has optical alignment.

同樣地,現有文獻2中記載的由包含具有肉桂醯基及環氧基的聚合體以及多官能羧基化合物的硬化性組成物獲得的硬化膜也進行三維交聯,且具有光配向性。Similarly, a cured film obtained from a curable composition containing a polymer having a cinnamyl group and an epoxy group and a polyfunctional carboxyl compound described in Conventional Document 2 is also three-dimensionally cross-linked and has optical alignment.

但是,關於本發明的硬化性組成物與現有文獻2中記載的硬化性組成物,具有光配向性的化合物與主要成分中的其他成分的交聯性不同。However, regarding the curable composition of the present invention and the curable composition described in Conventional Document 2, the compound having a photo-alignment property differs from the other components in the main component in crosslinkability.

本發明的硬化性組成物中所含的具有光配向性的化合物即醯亞胺化合物(A)的交聯性基為烷氧基矽烷基,因此關於主要成分中的其他成分的交聯性基,與多官能羧基化合物(B)的羧基及多官能環氧化合物(C)的環氧基的交聯性均低。The crosslinkable group of the amide imide compound (A) contained in the curable composition of the present invention, which is a photo-alignable compound, is an alkoxysilyl group, so the crosslinkable groups of other components in the main component The crosslinkability with the carboxyl group of the polyfunctional carboxyl compound (B) and the epoxy group of the polyfunctional epoxy compound (C) is low.

另一方面,現有文獻2中記載的硬化性組成物中所含的作為具有光配向性的化合物的具有肉桂醯基及環氧基的聚合體的交聯性基即環氧基是主要成分中的其他成分的交聯性基與多官能羧基化合物的羧基的交聯性高。On the other hand, the epoxy group, which is a crosslinkable group of a polymer having a cinnamoyl group and an epoxy group, which is a compound having a photo-alignment contained in the curable composition described in Conventional Document 2, is the main component. The crosslinkability of other components of the compound is high in crosslinkability with the carboxyl group of the multifunctional carboxyl compound.

因此,在本發明的硬化性組成物進行硬化時,由具有光配向性的化合物及主要成分中的其他成分的交聯引起的光配向性的阻礙小,相對於此,在現有文獻2中記載的硬化性組成物進行硬化時,由具有光配向性的化合物及主要成分中的其他成分的交聯引起的光配向性的阻礙大。因此,關於本發明的硬化性組成物,即便在具有光配向性的成分的調配率低的情況下,所獲得的硬化膜也可具有光配向性。因此,在將不含具有光配向性的成分的硬化性組成物與添加有具有光配向性的成分的硬化性組成物加以比較的情況下,可抑制由具有光配向性的成分的添加引起的光配向性以外的特性的降低。Therefore, when the curable composition of the present invention is cured, the hindrance of photoalignment caused by the crosslinking of the compound having photoalignment and the other components of the main component is small, and this is described in Conventional Document 2 When the curable composition is cured, the photo-alignment caused by the cross-linking of the compound having photo-alignment and other components in the main component is greatly hindered. Therefore, regarding the curable composition of the present invention, even when the compounding ratio of the component having photo-alignment is low, the obtained cured film may have photo-alignment. Therefore, when the curable composition containing no photoalignment component is compared with the curable composition added with photoalignment component, the addition of the photoalignment component can be suppressed. Degradation of characteristics other than optical alignment.

<3.包括由硬化性組成物獲得的硬化膜的彩色濾光片基板> 包括本發明的硬化膜的彩色濾光片基板為在彩色濾光片基板的著色體上形成有本發明的硬化膜的彩色濾光片基板。<3. Color filter substrate including a cured film obtained from a curable composition> The color filter substrate including the hardened film of the present invention is a color filter substrate in which the hardened film of the present invention is formed on the color body of the color filter substrate.

本發明的硬化性組成物的平坦化性高,因此通過包括硬化膜而減低彩色濾光片基板表面的階差。因此,在將包括本發明的硬化膜的彩色濾光片基板用於顯示元件中時,顯示元件的顯示品質高。 [實施例]Since the curable composition of the present invention has high flatness, the step of the surface of the color filter substrate is reduced by including the cured film. Therefore, when a color filter substrate including the cured film of the present invention is used in a display element, the display quality of the display element is high. [Example]

繼而,通過合成例、比較合成例、實施例及比較例而對本發明進行具體說明,但本發明並不受這些實施例的任何限定。Next, the present invention will be specifically described through Synthesis Examples, Comparative Synthesis Examples, Examples, and Comparative Examples, but the invention is not limited to these Examples.

對於合成例、比較合成例、實施例及比較例中所使用的化合物,針對每一成分而預先記載。The compounds used in Synthesis Examples, Comparative Synthesis Examples, Examples, and Comparative Examples are described in advance for each component.

具有聚合性雙鍵的酸酐(a1): a1-1:檸康酸酐 a1-2:馬來酸酐 a1-3:衣康酸酐 具有氨基的烷氧基矽烷基化合物(a2): a2-1:3-氨基丙基三乙氧基矽烷(以下簡記為「APTS」) 醯亞胺化合物(A)的合成中所使用的合成溶劑: EDM、PGME 醯亞胺化合物(A)的合成中所使用的聚合抑制劑: 二丁基羥基甲苯(以下簡記為「BHT」)Anhydride with polymerizable double bond (a1): a1-1: citraconic anhydride a1-2: Maleic anhydride a1-3: Itaconic anhydride Alkoxy silane compounds with amino groups (a2): a2-1: 3-aminopropyltriethoxysilane (hereinafter abbreviated as "APTS") Synthetic solvents used in the synthesis of amide imine compounds (A): EDM, PGME Polymerization inhibitor used in the synthesis of amide imine compound (A): Dibutylhydroxytoluene (hereinafter abbreviated as "BHT")

四羧酸二酐(b11): b11-1:丁烷四羧酸二酐(商品名,理家德(Rikacid)BT-100,新日本理化股份有限公司,以下簡記為「BT-100」) b11-2:3,3',4,4'-二苯基醚四羧酸二酐(以下簡記為「ODPA」) 二胺(b12): b12-1:3,3'-二氨基二苯基碸(以下簡記為「DDS」) 多元羥基化合物(b13): b13-1:1,4-丁二醇 一元醇(b14): b14-1:苄醇 苯乙烯-馬來酸酐共聚物(b15): b15-1:SMA1000(商品名,川原油化股份有限公司) 聚酯醯胺酸(B1)的反應中所使用的聚合溶劑: MMP、PGMEATetracarboxylic dianhydride (b11): b11-1: Butane tetracarboxylic dianhydride (trade name, Rikacid BT-100, New Japan Physical and Chemical Corporation, hereinafter referred to as "BT-100") b11-2: 3,3',4,4'-diphenyl ether tetracarboxylic dianhydride (hereinafter abbreviated as "ODPA") Diamine (b12): b12-1: 3,3'-diaminodiphenyl ash (hereinafter abbreviated as "DDS") Polyhydroxy compound (b13): b13-1: 1,4-butanediol Monohydric alcohol (b14): b14-1: benzyl alcohol Styrene-maleic anhydride copolymer (b15): b15-1: SMA1000 (trade name, Sichuan Crude Oil Chemical Co., Ltd.) Polymerization solvent used in the reaction of polyester amide acid (B1): MMP, PGMEA

多官能環氧化合物(C): C-1:作為具有三個以上的縮水甘油醚基的化合物的jER 157S70(商品名,三菱化學股份有限公司,以下簡記為「157S70」) C-2:作為具有三個以上的縮水甘油酯基的化合物的甲基丙烯酸縮水甘油酯的均聚物的PGMEA溶液(固體成分濃度為50重量%,重量平均分子量為3,000,以下記載為「PGMA3000」) C-3:作為具有三個以上的氧雜環丙基的化合物的EHPE3150(商品名,大賽璐(Daicel)股份有限公司)Multifunctional epoxy compound (C): C-1: jER 157S70 as a compound having three or more glycidyl ether groups (trade name, Mitsubishi Chemical Corporation, hereinafter abbreviated as "157S70") C-2: PGMEA solution of a homopolymer of glycidyl methacrylate as a compound having three or more glycidyl ester groups (solid content concentration of 50% by weight, weight average molecular weight of 3,000, hereinafter described as "PGMA3000 ") C-3: EHPE3150 as a compound having three or more oxetanyl groups (trade name, Daicel Corporation)

添加劑(D): D-1:作為受阻酚系抗氧化劑的艾迪科斯塔波(ADK STAB)AO-60(商品名,艾迪科(ADEKA)股份有限公司,以下簡記為「AO-60」)Additive (D): D-1: ADK STAB AO-60 as a hindered phenolic antioxidant (trade name, ADEKA Co., Ltd., hereinafter abbreviated as "AO-60")

稀釋用溶劑(E): E-1:PGME E-2:PGBE E-3:EDM E-4:PGMEA E-5:MMP E-6:CPNSolvent for dilution (E): E-1: PGME E-2: PGBE E-3: EDM E-4: PGMEA E-5: MMP E-6: CPN

首先,以如下所示的方式合成含有醯亞胺化合物(A)的溶液(合成例1~合成例3)。First, a solution containing the amide imine compound (A) (Synthesis Example 1 to Synthesis Example 3) was synthesized as follows.

[合成例1]含有醯亞胺化合物(A-1)的溶液的合成 在包括溫度計、攪拌機、原料投入裝入口及氮氣導入口的500 mL的四口燒瓶中,以下述重量裝入作為具有聚合性雙鍵的酸酐(a1)的檸康酸酐、作為具有氨基的烷氧基矽烷基化合物(a2)的APTS及作為合成溶劑的EDM,在設定為130℃的油浴中加熱3小時,進而設定為145℃而老化2小時,並且在常壓下將低沸點成分蒸餾去除。 檸康酸酐 64.51 g APTS 127.49 g EDM 48.00 g 將反應液冷卻至30℃以下,從而獲得含有醯亞胺化合物(A-1)的溶液。對溶液的一部分進行取樣,通過GPC分析來測定重量平均分子量,並利用乾燥重量法來測定固體成分濃度。這些的結果,重量平均分子量為2,150,固體成分濃度為78重量%。再者,作為原料裝入的具有聚合性雙鍵的酸酐(a1)的酸酐基及具有氨基的烷氧基矽烷基化合物(a2)的氨基的莫耳比(酸酐基/氨基)為1.0。[Synthesis Example 1] Synthesis of solution containing amide imine compound (A-1) In a 500 mL four-necked flask including a thermometer, a stirrer, a raw material charging inlet, and a nitrogen gas inlet, citraconic anhydride, which is an acid anhydride (a1) having a polymerizable double bond, and alkoxy, which has an amino group, are charged with the following weights The APTS of the silane-based compound (a2) and EDM as a synthesis solvent were heated in an oil bath set at 130°C for 3 hours, and then aged at 145°C for 2 hours, and the low-boiling components were distilled off under normal pressure . Citraconic anhydride 64.51 g APTS 127.49 g EDM 48.00 g The reaction liquid was cooled to 30° C. or lower to obtain a solution containing an amide imine compound (A-1). A part of the solution was sampled, the weight average molecular weight was measured by GPC analysis, and the solid content concentration was measured by dry weight method. As a result of these, the weight average molecular weight was 2,150, and the solid content concentration was 78% by weight. In addition, the molar ratio (anhydride group/amino group) of the amino group of the acid anhydride (a1) having a polymerizable double bond and the amino group of the alkoxysilane group compound (a2) charged as raw materials was 1.0.

[合成例2]含有醯亞胺化合物(A-2)的溶液的合成 在包括溫度計、攪拌機、原料投入裝入口及氮氣導入口的200 mL的四口燒瓶中,以下述重量裝入作為具有聚合性雙鍵的酸酐(a1)的馬來酸酐、作為具有氨基的烷氧基矽烷基化合物(a2)的APTS、作為聚合抑制劑的BHT及作為合成溶劑的EDM,在設定為100℃的油浴中加熱3小時,進而設定為120℃而老化2小時,並且在常壓下將低沸點成分蒸餾去除。 馬來酸酐 10.00 g APTS 22.58 g BHT 0.0163 g EDM 21.72 g 將反應液冷卻至30℃以下,從而獲得含有醯亞胺化合物(A-2)的溶液。對溶液的一部分進行取樣,通過GPC分析來測定重量平均分子量,並利用乾燥重量法來測定固體成分濃度。這些的結果,重量平均分子量為2,850,固體成分濃度為58重量%。再者,作為原料裝入的具有聚合性雙鍵的酸酐(a1)的酸酐基及具有氨基的烷氧基矽烷基化合物(a2)的氨基的莫耳比(酸酐基/氨基)為1.0。[Synthesis Example 2] Synthesis of solution containing amide imine compound (A-2) In a 200 mL four-necked flask including a thermometer, a stirrer, a raw material charging inlet, and a nitrogen gas inlet, maleic anhydride, which is an acid anhydride (a1) having a polymerizable double bond, and alkoxy, which has an amino group, are charged with the following weights The APTS of the silane-based compound (a2), BHT as a polymerization inhibitor, and EDM as a synthesis solvent are heated in an oil bath set at 100°C for 3 hours, and then set at 120°C for 2 hours, and at normal pressure Next, the low boiling point components are distilled off. Maleic anhydride 10.00 g APTS 22.58 g BHT 0.0163 g EDM 21.72 g The reaction liquid was cooled to 30° C. or lower to obtain a solution containing an amide imine compound (A-2). A part of the solution was sampled, the weight average molecular weight was measured by GPC analysis, and the solid content concentration was measured by dry weight method. As a result of these, the weight average molecular weight was 2,850, and the solid content concentration was 58% by weight. In addition, the molar ratio (acid anhydride group/amino group) of the acid anhydride group of the acid anhydride (a1) having a polymerizable double bond and the amino group of the alkoxysilane group compound (a2) having an amino group charged as raw materials was 1.0.

[合成例3]含有醯亞胺化合物(A-3)的溶液的合成 在包括溫度計、攪拌機、原料投入裝入口及氮氣導入口的200 mL的四口燒瓶中,以下述重量裝入作為具有聚合性雙鍵的酸酐(a1)的衣康酸酐、作為具有氨基的烷氧基矽烷基化合物(a2)的APTS、作為聚合抑制劑的BHT及作為合成溶劑的PGME,在設定為100℃的油浴中加熱3小時,進而設定為120℃而老化2小時,並且在常壓下將低沸點成分蒸餾去除。 衣康酸酐 8.00 g APTS 15.80 g BHT 0.0119 g PGME 23.81 g 將反應液冷卻至30℃以下,從而獲得含有醯亞胺化合物(A-3)的溶液。對溶液的一部分進行取樣,通過GPC分析來測定重量平均分子量,並利用乾燥重量法來測定固體成分濃度。這些的結果,重量平均分子量為1,100,固體成分濃度為49重量%。再者,作為原料裝入的具有聚合性雙鍵的酸酐(a1)的酸酐基及具有氨基的烷氧基矽烷基化合物(a2)的氨基的莫耳比(酸酐基/氨基)為1.0。[Synthesis Example 3] Synthesis of solution containing amide imine compound (A-3) In a 200 mL four-necked flask including a thermometer, a stirrer, a raw material inlet, and a nitrogen inlet, itaconic anhydride, which is an acid anhydride (a1) having a polymerizable double bond, and alkoxy, which has an amino group, are charged with the following weights The APTS of the silane-based compound (a2), BHT as a polymerization inhibitor, and PGME as a synthesis solvent were heated in an oil bath set at 100°C for 3 hours, and then set at 120°C for 2 hours, and at normal pressure Next, the low boiling point components are distilled off. Itaconic anhydride 8.00 g APTS 15.80 g BHT 0.0119 g PGME 23.81 g The reaction liquid was cooled to 30° C. or lower to obtain a solution containing an amide imine compound (A-3). A part of the solution was sampled, the weight average molecular weight was measured by GPC analysis, and the solid content concentration was measured by dry weight method. As a result of these, the weight average molecular weight was 1,100, and the solid content concentration was 49% by weight. In addition, the molar ratio (acid anhydride group/amino group) of the acid anhydride group of the acid anhydride (a1) having a polymerizable double bond and the amino group of the alkoxysilane group compound (a2) having an amino group charged as raw materials was 1.0.

使用包含四羧酸二酐、二胺、多元羥基化合物的原料,以如下所示的方式合成含有聚酯醯胺酸的溶液(合成例4及合成例5)。Using a raw material containing tetracarboxylic dianhydride, diamine, and polyhydroxy compound, a solution containing polyester amide acid was synthesized as follows (Synthesis Example 4 and Synthesis Example 5).

[合成例4]含有聚酯醯胺酸(B1-1)的溶液的合成 在包括溫度計、攪拌機、原料投入裝入口及氮氣導入口的1,000 mL的四口燒瓶中,裝入604.80 g的作為合成反應中所使用的溶劑的PGMEA、34.47 g的作為四羧酸二酐的BT-100、164.11 g的作為苯乙烯-馬來酸酐共聚物的SMA1000、50.17 g的作為單羥基化合物的苄醇、10.45 g的作為多元羥基化合物的1,4-丁二醇,在乾燥氮氣氣流下且在130℃下攪拌3小時。其後,將反應後的溶液冷卻至25℃,並投入10.80 g的作為二胺的DDS、25.20 g的PGMEA,在20℃~30℃下攪拌2小時後,在115℃下攪拌1小時,並冷卻至30℃以下,由此獲得淡黃色透明的固體成分濃度為30重量%的含有聚酯醯胺酸(B1-1)的溶液。利用GPC測定而得的重量平均分子量為10,000。[Synthesis Example 4] Synthesis of a solution containing polyester amide acid (B1-1) In a 1,000 mL four-necked flask including a thermometer, stirrer, raw material inlet, and nitrogen inlet, 604.80 g of PGMEA as the solvent used in the synthesis reaction and 34.47 g of BT as the tetracarboxylic dianhydride -100, 164.11 g of SMA1000 as a styrene-maleic anhydride copolymer, 50.17 g of benzyl alcohol as a monohydroxy compound, and 10.45 g of 1,4-butanediol as a polyhydroxy compound under a dry nitrogen gas flow And it was stirred at 130°C for 3 hours. Thereafter, the solution after the reaction was cooled to 25°C, and 10.80 g of DDS as a diamine and 25.20 g of PGMEA were added, stirred at 20°C to 30°C for 2 hours, and then stirred at 115°C for 1 hour, and After cooling to 30° C. or lower, a light yellow transparent solution containing polyester amidic acid (B1-1) with a solid content concentration of 30% by weight was obtained. The weight average molecular weight measured by GPC was 10,000.

[合成例5]含有聚酯醯胺酸(B1-2)的溶液的合成 在包括溫度計、攪拌機、原料投入裝入口及氮氣導入口的1,000 mL的四口燒瓶中,裝入446.96 g的作為合成反應中所使用的溶劑的MMP、31.93 g的作為多元羥基化合物的1,4-丁二醇、25.54 g的作為單羥基化合物的苄醇、183.20 g的作為四羧酸二酐的ODPA,在乾燥氮氣氣流下且在130℃下攪拌3小時。其後,將反應後的溶液冷卻至25℃,並投入29.33 g的作為二胺的DDS、183.04 g的MMP,在20℃~30℃下攪拌2小時後,在115℃下攪拌1小時,並冷卻至30℃以下,由此獲得淡黃色透明的固體成分濃度為30重量%的含有聚酯醯胺酸(B1-2)的溶液。另外,利用GPC測定而得的重量平均分子量為4,200。[Synthesis Example 5] Synthesis of a solution containing polyester amide acid (B1-2) In a 1,000 mL four-necked flask including a thermometer, stirrer, raw material inlet and nitrogen inlet, 446.96 g of MMP as the solvent used in the synthesis reaction and 31.93 g of 1,4 as the polyhydroxy compound -Butanediol, 25.54 g of benzyl alcohol as a monohydroxy compound, and 183.20 g of ODPA as a tetracarboxylic dianhydride were stirred at 130° C. for 3 hours under a stream of dry nitrogen. Thereafter, the solution after the reaction was cooled to 25°C, and 29.33 g of DDS as a diamine and 183.04 g of MMP were added, stirred at 20°C to 30°C for 2 hours, and then stirred at 115°C for 1 hour, and It cooled to 30 degreeC or less, and obtained the solution containing the polyester amidic acid (B1-2) with a pale yellow transparent solid content concentration of 30 weight%. In addition, the weight average molecular weight measured by GPC was 4,200.

使用包含具有肉桂醯基的聚合性化合物及具有環氧基的聚合性化合物的原料,以如下所示的方式合成含有具有肉桂醯基及環氧基的聚合體(Z)的溶液(合成例6)。Using a raw material containing a polymerizable compound having a cinnamoyl group and an polymerizable compound having an epoxy group, a solution containing a polymer (Z) having a cinnamoyl group and an epoxy group was synthesized as follows (Synthesis Example 6) ).

[合成例6]含有具有肉桂醯基及環氧基的聚合體(Z-1)的溶液的合成 在包括溫度計、攪拌機、原料投入裝入口及氮氣導入口的500 mL的四口燒瓶中,裝入135.00 g的作為具有肉桂醯基的聚合性化合物的2-丙烯酸-2-{4-[(1E)-3-甲氧基-3-側氧基-1-丙烯-1-基]苯氧基}乙基=2-甲酯、15.00 g的作為具有環氧基的聚合性化合物的甲基丙烯酸縮水甘油酯、15.00 g的作為聚合起始劑的2,2'-偶氮雙(2,4-二甲基戊腈)、50.00 g的作為反應溶媒的CPN,在90℃的聚合溫度下加熱2小時而進行聚合。將反應後的溶液冷卻至30℃以下,由此獲得固體成分濃度為25重量%的含有具有肉桂醯基及環氧基的聚合體(Z-1)的溶液。另外,利用GPC測定而得的重量平均分子量為6,400。[Synthesis Example 6] Synthesis of a solution containing a polymer (Z-1) having a cinnamyl group and an epoxy group Into a 500 mL four-necked flask including a thermometer, a stirrer, a raw material inlet and a nitrogen inlet, 135.00 g of 2-acrylic acid-2-{4-[(1E )-3-methoxy-3- pendant-1-propen-1-yl]phenoxy}ethyl=2-methyl ester, 15.00 g of methacrylic acid as a polymerizable compound having an epoxy group Glycidyl ester, 15.00 g of 2,2'-azobis(2,4-dimethylvaleronitrile) as a polymerization initiator, and 50.00 g of CPN as a reaction solvent, heated at a polymerization temperature of 90°C Polymerization took place in 2 hours. The solution after the reaction was cooled to 30° C. or lower to obtain a solution containing a polymer (Z-1) having a cinnamyl group and an epoxy group with a solid content concentration of 25% by weight. In addition, the weight average molecular weight measured by GPC was 6,400.

[實施例1] 以表1中記載的比例(單位:g)將作為含有醯亞胺化合物(A)的溶液的合成例1中所獲得的含有醯亞胺化合物(A-1)的溶液、作為含有多官能羧基化合物(B)的溶液的合成例4中所獲得的含有聚酯醯胺酸(B1-1)的溶液、作為多官能環氧化合物(C)的157S70、以及作為稀釋用溶劑(E)的PGBE、EDM及PGMEA混合溶解,利用薄膜過濾器(0.2 μm)進行過濾,從而獲得硬化性組成物。[Example 1] The solution containing the amide imide compound (A-1) obtained in Synthesis Example 1 as the solution containing the amide imide compound (A) was used as the solution containing the polyfunctional carboxyl group at the ratio (unit: g) described in Table 1. The solution containing the compound amide acid (B1-1) obtained in Synthesis Example 4 of the solution of the compound (B), 157S70 as the multifunctional epoxy compound (C), and PGBE as the solvent for dilution (E) , EDM and PGMEA are mixed and dissolved, and filtered with a membrane filter (0.2 μm) to obtain a hardening composition.

將醯亞胺化合物(A)、多官能羧基化合物(B)及多官能環氧化合物(C)的總量100重量%中的醯亞胺化合物(A)的比例(單位:重量%,表中記載為「100×(A)/[(A)+(B)+(C)]」)示於表1中。Proportion of the imidate compound (A) in the total amount of acetimidate compound (A), polyfunctional carboxy compound (B) and polyfunctional epoxy compound (C) 100% by weight (unit:% by weight, in the table "100×(A)/[(A)+(B)+(C)]") is shown in Table 1.

將多官能羧基化合物(B)及多官能環氧化合物(C)的總量100重量%中的多官能羧基化合物(B)的比例(單位:重量%,表中記載為「100×(B)/[(B)+(C)]」)示於表1中。The proportion of the polyfunctional carboxyl compound (B) in the total amount of the polyfunctional carboxyl compound (B) and the polyfunctional epoxy compound (C) 100% by weight (unit:% by weight, described in the table as "100×(B) /[(B)+(C)]”) is shown in Table 1.

表1

Figure 108122409-A0304-0001
Table 1
Figure 108122409-A0304-0001

表1(續)

Figure 108122409-A0304-0002
表中的(A-1)、(A-2)、(A-3)、(B1-1)、(B1-2)及(Z-1)為溶液的重量。Table 1 (continued)
Figure 108122409-A0304-0002
(A-1), (A-2), (A-3), (B1-1), (B1-2) and (Z-1) in the table are the weight of the solution.

再者,實施例1的硬化性組成物中所含的溶劑的總量為含有醯亞胺化合物(A-1)的溶液中所含的反應溶劑即EDM、以及稀釋用溶劑(E)的PGBE、EDM及PGMEA的總量,利用所述步驟而製備成固體成分濃度成為大約25重量%。在實施例2之後的實施例及比較例中也相同。In addition, the total amount of the solvent contained in the curable composition of Example 1 is PGBE which is the reaction solvent contained in the solution containing the amide imine compound (A-1), and the dilution solvent (E) The total amount of EDM, PDMA, and PGMEA was prepared by the above-mentioned procedure so that the solid content concentration became approximately 25% by weight. The same also applies to Examples and Comparative Examples after Example 2.

[帶有硬化膜的玻璃基板的製作] 以800 rpm歷時10秒將所獲得的硬化性組成物旋塗於玻璃基板上,並在80℃的加熱板上預烘烤3分鐘,由此獲得帶有塗膜的基板。進而,在230℃的烘箱內後烘烤30分鐘,由此獲得硬化膜的膜厚為大致1.5 μm的帶有硬化膜的基板。以下,將所獲得的所述帶有硬化膜的基板表述為「帶有硬化膜的玻璃基板」。[Fabrication of glass substrate with cured film] The obtained curable composition was spin-coated on a glass substrate at 800 rpm for 10 seconds, and prebaked on a hot plate at 80° C. for 3 minutes, thereby obtaining a substrate with a coating film. Furthermore, post-baking in an oven at 230° C. for 30 minutes, a substrate with a cured film having a cured film thickness of approximately 1.5 μm was obtained. Hereinafter, the obtained substrate with a cured film is expressed as "glass substrate with a cured film".

[黏性評價] 對所述帶有塗膜的基板的塗膜的發黏情況進行確認。將無黏性(不發黏)的情況評價為黏性「◎」,將雖不發黏但強力按壓時殘留指紋的情況評價為黏性「○」,將發黏的情況評價為黏性「×」,將為液狀的情況評價為黏性「××」。將評價結果示於表1中。[Viscosity evaluation] The stickiness of the coating film of the substrate with the coating film was confirmed. The non-sticky (non-sticky) case is evaluated as sticky "◎", the non-sticky but residual fingerprint when pressed strongly is evaluated as sticky "○", and the sticky case is evaluated as sticky " ×", the liquid state is evaluated as the viscosity "××". Table 1 shows the evaluation results.

[透光率的測定] 使用紫外可見近紅外分光光度計V-670(商品名,日本分光股份有限公司),並在紫外可見近紅外分光光度計的參考側設置未形成硬化膜的玻璃基板,在樣品側設置所獲得的帶有硬化膜的玻璃基板,由此測定僅硬化膜在光的波長為400 nm下的透光率。將測定值示於表1中。[Measurement of light transmittance] Use a UV-visible near-infrared spectrophotometer V-670 (trade name, Japan Spectroscopy Co., Ltd.), and set a glass substrate on which the hardened film is not formed on the reference side of the ultraviolet-visible near-infrared spectrophotometer and set the obtained on the sample side For a glass substrate with a cured film, the transmittance of only the cured film at a wavelength of light of 400 nm was measured. Table 1 shows the measured values.

[透明性的評價] 將透光率為99.0%以上的情況評價為透明性「◎」,將97.0%以上且未滿99.0%的情況評價為透明性「○」,將未滿97.0%的情況評價為透明性「×」。將評價結果示於表1中。[Evaluation of transparency] The case where the light transmittance is 99.0% or more is evaluated as transparency "◎", the case where 97.0% or more and less than 99.0% is evaluated as transparency "○", and the case where less than 97.0% is evaluated as transparency "×" ". Table 1 shows the evaluation results.

[5%重量減少溫度的算出] 自所獲得的帶有硬化膜的玻璃基板的硬化膜削出粉末狀的測定用試樣。使用示差熱天平Thermo plus EVO TG-DTA 8120(商品名,理學股份有限公司)來測定所獲得的試樣的熱重量減少率的溫度依存性。自室溫以10℃/min的升溫速度進行加熱,以100℃的熱重量減少率為基準而算出重量減少率成為5%的溫度即「5%重量減少溫度」。將算出值示於表1中。[Calculation of 5% weight loss temperature] A powdery sample for measurement was cut out from the obtained cured film of the glass substrate with a cured film. The temperature dependence of the thermal weight loss rate of the obtained sample was measured using a differential thermal balance Thermo plus EVO TG-DTA 8120 (trade name, Rigaku Corporation). The temperature was heated from a room temperature at a temperature increase rate of 10°C/min, and the temperature at which the weight reduction rate became 5% based on the thermal weight reduction rate of 100°C was calculated as the “5% weight reduction temperature”. Table 1 shows the calculated values.

[耐熱性的評價] 將5%重量減少溫度為310℃以上的情況評價為耐熱性「◎」,將290℃以上且未滿310℃的情況評價為耐熱性「○」,將未滿290℃的情況評價為耐熱性「×」。將評價結果示於表1中。[Evaluation of heat resistance] The case where the 5% weight loss temperature is 310°C or higher is evaluated as heat resistance “◎”, the case where the temperature is 290°C or higher and less than 310°C is evaluated as heat resistance “○”, and the case where the temperature is less than 290°C is evaluated as heat resistance "×". Table 1 shows the evaluation results.

[聚合性液晶組成物的製備] 以如下方式製備評價中所使用的聚合性液晶組成物。添加5.0 g的帕裡奧卡拉(Paliocolor)LC242(商品名,日本巴斯夫(BASF Japan)股份有限公司)、0.25 g的豔佳固(IRGACURE)907(商品名,日本巴斯夫(BASF Japan)股份有限公司)、0.0050 g的BYK361N(商品名,日本畢克化學(BYK Chemie Japan)股份有限公司)以及作為有機溶媒的甲苯,以有機溶媒成為整體的85重量%的方式製備,並均勻地混合溶解。將所述組成物設為聚合性液晶組成物(PLC-1)。[Preparation of polymerizable liquid crystal composition] The polymerizable liquid crystal composition used in the evaluation was prepared as follows. Add 5.0 g of Paliocolor LC242 (trade name, BASF Japan Co., Ltd.), 0.25 g of IRGACURE 907 (trade name, BASF Japan) Co., Ltd. ), 0.0050 g of BYK361N (trade name, BYK Chemie Japan) Co., Ltd. and toluene as an organic solvent are prepared in such a way that the organic solvent is 85% by weight as a whole, and are uniformly mixed and dissolved. Let the said composition be a polymerizable liquid crystal composition (PLC-1).

[帶有光學功能膜的玻璃基板的製作] 使由超高壓水銀燈照射的光通過截止300 nm以下的光的濾光片與線柵偏光板而轉換為直線偏光,並以313 nm換算計對所獲得的帶有硬化膜的玻璃基板照射500 mJ/cm2[Fabrication of glass substrate with optical function film] The light irradiated by the ultra-high pressure mercury lamp is converted into linear polarized light through a filter and a wire grid polarizing plate that cut off light below 300 nm, and is converted into 313 nm The obtained glass substrate with a cured film was irradiated with 500 mJ/cm 2 .

繼而,以1,300 rpm的轉速歷時10秒將聚合性液晶組成物(PLC-1)旋塗於所述基板上,在加熱板上且在80℃下預烘烤1分鐘。將基板冷卻至室溫後,以365 nm換算計照射300 mJ/cm2 的超高壓水銀燈的全線,將聚合性液晶組成物光硬化,從而將配向固定化。以下,將所獲得的所述基板表述為「帶有光學功能膜的玻璃基板」。Then, the polymerizable liquid crystal composition (PLC-1) was spin-coated on the substrate at a rotation speed of 1,300 rpm for 10 seconds, and prebaked on a hot plate at 80° C. for 1 minute. After cooling the substrate to room temperature, the entire line of an ultra-high pressure mercury lamp of 300 mJ/cm 2 was irradiated in 365 nm conversion, and the polymerizable liquid crystal composition was photohardened to fix the alignment. Hereinafter, the obtained substrate is expressed as "glass substrate with optical functional film".

[光配向性的評價] 將所獲得的帶有光學功能膜的玻璃基板夾持於正交(正交尼科耳(crossed nicols))狀態的兩片直線偏光板之間,自下方照射背光並進行觀察。將可無配向缺陷(無漏光)地明暗顯示的情況評價為光配向性「◎」,將雖可幾乎整體明暗顯示,但觀察到局部配向缺陷的情況評價為光配向性「○」,將其他情況評價為光配向性「×」。將評價結果示於表1中。[Evaluation of optical alignment] The obtained glass substrate with an optical function film was sandwiched between two linear polarizers in a crossed (crossed nicols) state, and the backlight was illuminated from below and observed. The light and dark display without alignment defects (no light leakage) is evaluated as light alignment "◎", and the light and dark display can be displayed as a whole, but the partial alignment defects are observed as light alignment "○", and the other The situation is evaluated as the optical alignment "×". Table 1 shows the evaluation results.

[帶有硬化膜的彩色濾光片基板的製作] 將玻璃基板變更為彩色濾光片基板,除此以外,依據帶有硬化膜的玻璃基板的製作方法而獲得帶有硬化膜的彩色濾光片基板。這裡,試驗中所使用的彩色濾光片基板為在玻璃基板上包括紅(R)、綠(G)及藍(B)的著色體以及防止混色用的黑色矩陣的基板,且最大階差為0.60 μm~0.65 μm。[Manufacture of color filter substrate with cured film] The glass substrate was changed to a color filter substrate, and otherwise, a color filter substrate with a cured film was obtained according to a method of manufacturing a glass substrate with a cured film. Here, the color filter substrate used in the experiment is a substrate including red (R), green (G), and blue (B) color bodies and a black matrix for preventing color mixing on a glass substrate, and the maximum step difference is 0.60 μm~0.65 μm.

[平坦化率的算出] 在帶有硬化膜的彩色濾光片基板的製作中,對塗布硬化性組成物前的彩色濾光片基板的最大階差(設為「TIR0 」)進行測定,在製作帶有硬化膜的彩色濾光片基板後,對所獲得的帶有硬化膜的彩色濾光片基板的最大階差(設為「TIR1 」)進行測定。根據所獲得的兩個最大階差,算出平坦化率=100%×[(TIR0 )-(TIR1 )]/(TIR0 )。將算出值示於表1中。[Calculation of flattening rate] In the preparation of a color filter substrate with a cured film, the maximum step difference (set to "TIR 0 ") of the color filter substrate before applying the curable composition was measured, After the color filter substrate with a cured film was produced, the maximum step difference (set to "TIR 1 ") of the obtained color filter substrate with a cured film was measured. Based on the two maximum order differences obtained, the flattening rate = 100% × [(TIR 0 )-(TIR 1 )]/(TIR 0 ) is calculated. Table 1 shows the calculated values.

[平坦化性的評價] 將平坦化率為50%以上的情況評價為平坦化性「○」,將平坦化率未滿50%的情況評價為平坦化性「×」。將評價結果示於表1中。[Evaluation of flatness] The case where the flattening rate is 50% or more is evaluated as the flattening property "○", and the case where the flattening rate is less than 50% is evaluated as the flattening property "×". Table 1 shows the evaluation results.

[實施例2~實施例11及比較例1~比較例4] 依據實施例1的方法,以表1中記載的比例(單位:g)將各成分混合溶解,從而獲得硬化性組成物。比較例2~比較例4中未記載多官能羧基化合物(B)及多官能環氧化合物(C)的總量100重量%中的多官能羧基化合物(B)的比例。比較例3及比較例4中,將多官能羧基化合物(B)以及具有肉桂醯基及環氧基的聚合體(Z)的總量100重量%中的具有肉桂醯基及環氧基的聚合體(Z)的比例(單位:重量%,表中記載為「100×(Z)/[(B)+(Z)]」)示於表1中。[Examples 2 to 11 and Comparative Examples 1 to 4] According to the method of Example 1, each component was mixed and dissolved in the ratio (unit: g) described in Table 1 to obtain a curable composition. Comparative Examples 2 to 4 do not describe the proportion of the polyfunctional carboxyl compound (B) in the total amount of 100% by weight of the polyfunctional carboxyl compound (B) and the polyfunctional epoxy compound (C). In Comparative Example 3 and Comparative Example 4, the polyfunctional carboxyl compound (B) and the polymer (Z) having a cinnamoyl group and epoxy group were polymerized with 100% by weight of the cinnamoyl group and epoxy group The ratio of the body (Z) (unit: weight %, described in the table as "100×(Z)/[(B)+(Z)]") is shown in Table 1.

依據實施例1的方法來評價黏性,根據透光率的測定值來評價透明性,根據5%重量減少溫度的算出值來評價耐熱性,並評價光配向性,根據平坦化率的算出值來評價平坦化性。將各自的測定值、算出值及評價結果示於表1中。其中,將硬化性組成物旋塗於玻璃基板上時的轉速是以硬化膜的膜厚成為大致1.5 μm的方式調整。The viscosity was evaluated according to the method of Example 1, the transparency was evaluated based on the measured value of light transmittance, the heat resistance was evaluated based on the calculated value of 5% weight loss temperature, and the optical alignment was evaluated, based on the calculated value of the flattening rate To evaluate flatness. Table 1 shows the respective measured values, calculated values, and evaluation results. However, the rotation speed when spin-coating the curable composition on the glass substrate is adjusted so that the thickness of the cured film becomes approximately 1.5 μm.

根據表1所示的結果而明確:實施例1~實施例11的硬化性組成物的黏性低且平坦化性優異,由所述硬化性組成物獲得的硬化膜的透明性、耐熱性及光配向性優異。另一方面,由不含醯亞胺化合物(A)的比較例1的硬化性組成物獲得的硬化膜的光配向性不良。不含多官能羧基化合物(B)及多官能環氧化合物(C)的比較例2中記載的硬化性組成物的黏性高且平坦化性不良。另外,由包含多官能羧基化合物(B)以及具有肉桂醯基及環氧基的聚合體(Z)的組成物即比較例3及比較例4的硬化性組成物獲得的硬化膜的透明性及耐熱性不良。From the results shown in Table 1, it is clear that the curable compositions of Examples 1 to 11 have low viscosity and excellent flatness, and the transparency, heat resistance and transparency of the cured film obtained from the curable composition Excellent optical alignment. On the other hand, the cured film obtained from the curable composition of Comparative Example 1 containing no amide imine compound (A) had poor optical alignment. The curable composition described in Comparative Example 2 without the polyfunctional carboxyl compound (B) and the polyfunctional epoxy compound (C) had high viscosity and poor flatness. In addition, the transparency and the transparency of the cured film obtained from the curable compositions of Comparative Examples 3 and 4 comprising the polyfunctional carboxyl compound (B) and the polymer (Z) having a cinnamyl group and an epoxy group Poor heat resistance.

[產業上的可利用性] 本發明的硬化性組成物的黏性低且平坦化性優異,由本發明的硬化性組成物獲得的硬化膜的透明性、耐熱性及光配向性優異,因此可用作具有光配向性的彩色濾光片保護膜。[Industry availability] The curable composition of the present invention has low viscosity and excellent flatness, and the cured film obtained from the curable composition of the present invention has excellent transparency, heat resistance, and optical alignment, and thus can be used as a color with optical alignment Filter protection film.

no

no

Claims (9)

一種硬化性組成物,其包含醯亞胺化合物(A)、多官能羧基化合物(B)及多官能環氧化合物(C),且 所述醯亞胺化合物(A)為來自將具有聚合性雙鍵的酸酐(a1)及具有氨基的烷氧基矽烷基化合物(a2)設為必需的原料的反應產物, 所述多官能羧基化合物(B)為每一分子具有三個以上的羧基的化合物, 所述多官能環氧化合物(C)為每一分子具有三個以上的環氧基的化合物。A hardening composition comprising an amide imine compound (A), a polyfunctional carboxyl compound (B) and a polyfunctional epoxy compound (C), and The amide imine compound (A) is a reaction product derived from an acid anhydride (a1) having a polymerizable double bond and an alkoxysilane group compound (a2) having an amino group as necessary raw materials, The multifunctional carboxyl compound (B) is a compound having three or more carboxyl groups per molecule, The multifunctional epoxy compound (C) is a compound having three or more epoxy groups per molecule. 如申請專利範圍第1項所述的硬化性組成物,其中在所述醯亞胺化合物(A)、所述多官能羧基化合物(B)及所述多官能環氧化合物(C)的總量100重量%中,所述醯亞胺化合物(A)為5重量%~80重量%; 在所述多官能羧基化合物(B)及所述多官能環氧化合物(C)的總量100重量%中,所述多官能羧基化合物(B)為20重量%~80重量%。The curable composition as described in item 1 of the patent application scope, wherein the total amount of the amide imine compound (A), the polyfunctional carboxyl compound (B) and the polyfunctional epoxy compound (C) 100% by weight, the amide imine compound (A) is 5% to 80% by weight; In the total amount of 100% by weight of the polyfunctional carboxyl compound (B) and the polyfunctional epoxy compound (C), the polyfunctional carboxyl compound (B) is 20% to 80% by weight. 如申請專利範圍第1項所述的硬化性組成物,其中在所述醯亞胺化合物(A)、所述多官能羧基化合物(B)及所述多官能環氧化合物(C)的總量100重量%中,所述醯亞胺化合物(A)為15重量%~60重量%; 在所述多官能羧基化合物(B)及所述多官能環氧化合物(C)的總量100重量%中,所述多官能羧基化合物(B)為40重量%~75重量%。The curable composition as described in item 1 of the patent application scope, wherein the total amount of the amide imine compound (A), the polyfunctional carboxyl compound (B) and the polyfunctional epoxy compound (C) 100% by weight, the amide imine compound (A) is 15% to 60% by weight; In the total amount of 100% by weight of the polyfunctional carboxyl compound (B) and the polyfunctional epoxy compound (C), the polyfunctional carboxyl compound (B) is 40% to 75% by weight. 如申請專利範圍第1項至第3項中任一項所述的硬化性組成物,其中所述具有聚合性雙鍵的酸酐(a1)為選自下述式(1)所表示的化合物及下述式(2)所表示的化合物中的至少一種;
Figure 03_image001
式(1)中,R1 及R2 分別獨立地為氫或碳數1~5的烷基;
Figure 03_image003
式(2)中,R3 為氫或碳數1~5的烷基。
The curable composition as described in any one of the first to third patent claims, wherein the acid anhydride (a1) having a polymerizable double bond is selected from a compound represented by the following formula (1) and At least one of the compounds represented by the following formula (2);
Figure 03_image001
In formula (1), R 1 and R 2 are each independently hydrogen or an alkyl group having 1 to 5 carbon atoms;
Figure 03_image003
In formula (2), R 3 is hydrogen or a C 1-5 alkyl group.
如申請專利範圍第1項至第4項中任一項所述的硬化性組成物,其中所述具有聚合性雙鍵的酸酐(a1)為選自馬來酸酐、檸康酸酐及衣康酸酐中的至少一種。The curable composition as described in any one of the first to fourth patent applications, wherein the acid anhydride (a1) having a polymerizable double bond is selected from maleic anhydride, citraconic anhydride and itaconic anhydride At least one of them. 如申請專利範圍第1項至第5項中任一項所述的硬化性組成物,其中所述具有氨基的烷氧基矽烷基化合物(a2)為選自3-氨基丙基三甲氧基矽烷、3-氨基丙基三乙氧基矽烷、4-氨基苯基三甲氧基矽烷及4-氨基苯基三乙氧基矽烷中的至少一種。The hardenable composition according to any one of claims 1 to 5 of the patent application, wherein the alkoxysilane group compound (a2) having an amino group is selected from 3-aminopropyltrimethoxysilane , At least one of 3-aminopropyltriethoxysilane, 4-aminophenyltrimethoxysilane and 4-aminophenyltriethoxysilane. 如申請專利範圍第1項至第6項中任一項所述的硬化性組成物,其中所述多官能羧基化合物(B)為將四羧酸二酐、二胺及多元羥基化合物設為必需原料的聚酯醯胺酸。The curable composition as described in any one of the patent application items 1 to 6, wherein the polyfunctional carboxyl compound (B) is a tetracarboxylic dianhydride, diamine, and polyhydroxy compound are required The raw material of polyester amide acid. 一種硬化膜,其是使如申請專利範圍第1項至第7項中任一項所述的硬化性組成物硬化而獲得。A cured film obtained by curing the curable composition according to any one of claims 1 to 7 of the patent application. 一種彩色濾光片基板,其包括如申請專利範圍第8項所述的硬化膜。A color filter substrate including the cured film as described in item 8 of the patent application.
TW108122409A 2018-07-26 2019-06-26 Curable compositions, cured film, and color filter substrate TWI814847B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018140208A JP7017126B2 (en) 2018-07-26 2018-07-26 Curable composition
JP2018-140208 2018-07-26

Publications (2)

Publication Number Publication Date
TW202007711A true TW202007711A (en) 2020-02-16
TWI814847B TWI814847B (en) 2023-09-11

Family

ID=69329038

Family Applications (1)

Application Number Title Priority Date Filing Date
TW108122409A TWI814847B (en) 2018-07-26 2019-06-26 Curable compositions, cured film, and color filter substrate

Country Status (4)

Country Link
JP (1) JP7017126B2 (en)
KR (1) KR20200012717A (en)
CN (1) CN110760257B (en)
TW (1) TWI814847B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113050212A (en) * 2021-01-12 2021-06-29 苏州群烨新材料科技有限公司 Infrared band-pass filter, preparation method thereof and imaging device with infrared band-pass filter

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0710966B2 (en) * 1987-12-04 1995-02-08 信越化学工業株式会社 Primer composition and its use
JPH09230364A (en) 1997-03-18 1997-09-05 Hitachi Ltd Liquid crystal display device
JP2003287617A (en) * 2002-03-28 2003-10-10 Toray Ind Inc Thermosetting resin solution composition for color filter, color filter and liquid crystal display device
JP5298428B2 (en) * 2006-12-26 2013-09-25 Jnc株式会社 Thermosetting resin composition and cured film
CN101965542B (en) * 2008-03-10 2013-03-27 旭化成电子材料株式会社 Photosensitive polyorganosiloxane composition
JP6079033B2 (en) * 2012-08-07 2017-02-15 Jnc株式会社 Photo / thermosetting composition
JP5994564B2 (en) 2012-10-22 2016-09-21 Jnc株式会社 Thermosetting composition having photo-alignment
JP2015049419A (en) * 2013-09-03 2015-03-16 Jnc株式会社 Composition for optical orientation film
CN105086316B (en) * 2014-05-15 2018-01-30 捷恩智株式会社 Thermosetting composition, cured film, colored filter, liquid crystal display cells, solid-state imager and LED illuminant heart
CN105062338A (en) * 2015-08-05 2015-11-18 天长市开林化工有限公司 Weatherproof aqueous alkyd resin/epoxy resin coating
JP6939110B2 (en) * 2016-07-13 2021-09-22 Jnc株式会社 Thermosetting composition

Also Published As

Publication number Publication date
CN110760257A (en) 2020-02-07
TWI814847B (en) 2023-09-11
CN110760257B (en) 2022-05-03
JP2020015841A (en) 2020-01-30
JP7017126B2 (en) 2022-02-08
KR20200012717A (en) 2020-02-05

Similar Documents

Publication Publication Date Title
TWI692505B (en) Photosensitive compositions and usage thereof
JP2017122912A (en) Photosensitive composition
JP2017078856A (en) Photosensitive composition
TW201903078A (en) Curable composition, hardened body, and liquid crystal display element
JP2012193339A (en) Thermosetting resin composition and cured film
TW201829552A (en) Polyester amide acids and photosensitive compositions containing the same
JP7218645B2 (en) Curable composition
TWI614309B (en) Thermosetting resin composition, hardened film, color filter, liquid crystal display device, solid state image device and light emitting diode luminous body
TWI814847B (en) Curable compositions, cured film, and color filter substrate
JP2018163340A (en) Photosensitive composition
CN110857371B (en) Cured film and color filter
TW201912708A (en) Thermosetting composition, cured film, and color filter
KR20180107716A (en) Photosensitive compositions
TWI813756B (en) Thermosetting compositions, cured film, and color filter
TWI774872B (en) Thermosetting composition, cured film and color filter
JP7119677B2 (en) thermosetting composition
JP6988566B2 (en) Thermosetting composition
TWI809170B (en) Thermosetting compositions, cured film, and color filter
JP2018146963A (en) Photosensitive composition
TW201837603A (en) Photosensitive compositions and application thereof capable of forming a cured film which is excellent in transparency, heat resistance, chemical resistance, flatness, resolution, and chemical resistance
JP2021059713A (en) Thermosetting composition
TW201827925A (en) Photosensitive composition and use thereof capable of forming a cured film excellent in transparency, heat resistance, solvent resistance, flatness, and resolution